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Inhibitory control (IC) is crucial in the ability to resist and impede habitual substance use. 
Workforce surveys have indicated a strong interest in the assessment of IC during substance use 
treatment. However, these are poorly utilised due to cost, accessibility and poor appeal. We have 
developed a brief, interactive IC task for smartphones and tablets. Our proposed measure uses a 
go/no-go paradigm; go-stimuli are bottles of healthy drinks and no-go stimuli are bottles of 
alcoholic drinks. Two studies were conducted to validate the task: a seven-day test-retest study, 
comprising both this test and traditional IC tasks in healthy adults (N=68, 40 females); and an 
acute alcohol dosing study designed to determine sensitivity to intoxication (BrAC=0.05%, 
0.08%; N=37, 22 females). The WAB demonstrated weak to moderate magnitude correlations 
with existing measures of IC and minimal learning effects on repeat assessment. Participants also 
reported greater acceptability of the WAB than a traditional IC measure. Finally, the WAB was a 
more sensitive measure to acute alcohol intoxication. Overall, the WAB demonstrates good face 
validity, equivalent reliability and greater sensitivity than traditional IC measures. Further 







Recent research has emphasised the importance of assessing cognition in substance 
dependence (Kwako, Momenan, Litten, Koob, & Goldman, 2016). For successful treatment to 
occur, substance-dependent individuals require the ability to integrate new information to modify 
habitual drug-seeking cognitions and behaviours (Brady, Gray, & Tolliver, 2011). However, the 
ability to perform these cognitive and behavioural modifications require intact cognition (Perry 
& Lawrence, 2017). It has been consistently demonstrated that substance-dependent individuals 
present with significant cognitive deficits (Brady et al., 2011). As a result, treatment success is 
compromised and continual substance use is maintained (Aharonovich et al., 2006). This 
relationship between cognitive deficits and poorer treatment outcomes is a key contributor to 
individuals remaining stuck in a cycle of dependence (Kwako et al., 2016).  
Addictions Neuroclinical Assessment Framework 
A neurobiological framework of addiction has been proposed; the Addictions 
Neuroclinical Assessment (ANA). This consists of three core neurofunctional domains; incentive 
salience, negative emotionality and executive function (EF) (Kwako et al., 2016). Kwako et al. 
(2016) claim that these domains explain the aetiology of addictive disorders and how their 
interactions lead to impulsive and compulsive behaviour. It is argued that the daily cycle of 
addiction consists of three phases, with a particular ANA domain being fundamental at each 
stage; incentive salience representing binge-intoxication, negative emotionality representing 
withdrawal-negative affect, and EF representing preoccupation-anticipation (Figure 1) (Koob & 
Le Moal, 2001). The persistent cycle of these stages and interaction of these three domains 
maintains the habitual behaviours, negative emotional states and anticipation associated with 






Figure 1. Addiction cycle and relevant ANA domains (Kwako et al., 2016).  
 
In the context of addiction, substances garner an incentive salience – a drive towards that 
stimuli through positive reinforcement (Kwako et al., 2017). Following chronic use of a 
substance, the absence of the drug produces an increase in negative emotionality (i.e., 
dysphoria). It is claimed that such negative affects drive continued substance use in an attempt to 
self-medicate these states (Kwako et al., 2016). This is maintained through negative 
reinforcement, whereby consumption of the substance temporarily reduces the negative 
emotionality or withdrawal state, perpetuating continued use (Koob & Volkow, 2016). 
A core component in the development and maintenance of addiction is executive 
dysfunction (Hester & Garavan, 2004). The ANA domain of EF constitutes a broad family of 
higher-order cognitive abilities that exert top-down control over mental processes that drive goal-
oriented behaviour (Alvarez & Emory, 2006). Impairments in EFs are widely apparent in 
substance use (Dominguez-Salas, Diaz-Batanero, Lozano-Rojas, & Verdejo-Garcia, 2016) and 




prefrontal cortex (Kwako et al., 2016). This dysfunction in the pre-frontal cortex has been shown 
to directly impact incentive salience and negative emotionality via glutamatergic and 
dopaminergic neuronal connections, further facilitating the cycle of addiction (Koob & Volkow, 
2016).  
Executive Function 
 A particular area of interest for this study is the ANA domain of EF. EF is claimed to 
comprise of three core functions, including inhibition, WM, and cognitive flexibility (Diamond, 
2013). This is supported by Miyake et al.’s (2000) three-factor model of EF, which demonstrates 
that these three core functions operate as separate processes, however, moderate correlations also 
exist between them, indicating that they have a reliance on a common underlying construct, 
namely EF.  
EFs have been consistently shown to be pertinent for the circumvention of maladaptive 
behaviours (Day, Kahler, Ahern, & Clark, 2015), with strong EF abilities being claimed to be 
protective against initiation of substance misuse (Perry & Lawrence, 2017). Consequently, it has 
been suggested that individuals with EF deficits may be at a higher risk of developing substance 
use problems (Finn, Justus, Mazas, & Steinmetz, 1999), have an increased susceptibility of 
further EF decline during substance use (Day et al., 2015), and have poorer treatment outcomes 
with limited success in remaining abstinent (Noel et al., 2002).  
Dysfunctions in EF have been extensively documented among individuals using addictive 
substances (Day et al., 2015; Dominguez-Salas et al., 2016; Jovanovski, Erb, & Zakzanis, 2005; 
Smith, Mattick, Jamadar, & Iredale, 2014). A comprehensive review by Spronk, van Wel, 
Ramaekers, and Verkes (2013) of 63 studies investigating the long-term cognitive effects of 




with the strongest deficits evident in response inhibition (Standardised mean difference 
(SMD)=0.64, 95% CI [0.44, 0.84]) and decision making (SMD = 0.53, 95% CI [0.32, 0.75]). In 
addition, meta-analytic evidence and systematic reviews have also demonstrated widespread 
deficits in EF in alcohol dependency (Stavro, Pelletier, & Potvin, 2013), chronic opiate use 
(Baldacchino, Balfour, Passetti, Humphris, & Matthews, 2012), methamphetamine dependency 
(Dean, Groman, Morales, & London, 2013), and chronic ecstasy use (Roberts, Jones, & 
Montgomery, 2016).  
Impairments in EF are not only apparent in substance dependence, but are also evident 
during recreational substance use, with the level of impairment differing between recreational- 
and substance-dependent populations (Ersche, Clark, London, Robbins, & Sahakian, 2006). This 
is supported by Vonmoos et al. (2013) who found that dependent cocaine users had significantly 
poorer cognitive functioning (d=1.04) compared to recreational cocaine users (d=0.48), 
suggesting that regular, dependent cocaine use produces greater impairments in EFs. 
Additionally, it is argued that remaining abstinent, or reducing substance use can improve EF 
prospectively (Schulte et al., 2014). A longitudinal study by Vonmoos et al. (2014) demonstrated 
that decreased cocaine use was associated with small improvements in EF (d=0.14). It was also 
found that cocaine users who ceased use reversed the deficits in EF, with their EF performance 
improving to levels consistent with psychostimulant-naïve controls (Vonmoos et al., 2014).  
Deficits in EF have also been argued to contribute to difficulty in maintaining therapeutic 
adherence and abstinence in substance dependence (Dominguez-Salas et al., 2016). Table 1 
illustrates the associations between EF and aspects of treatment outcome. As shown in Table 1, 
there is substantial variability among studies. This is in part due to the diversity of measures used 




Additionally, the heterogeneity of sex in study samples, such as male/female ratios, have also 
been argued to contribute to the inconsistencies in the literature (Aragues, Jurado, Quinto, & 
Rubio, 2011). This is supported by van der Plas, Crone, van den Wildenberg, Tranel, and 
Bechara (2009) who found that the EF domain of decision making was significantly more 
impaired in females dependent on methamphetamine or cocaine compared to males dependent on 
the same substances. This suggests that caution is needed when interpreting the results of studies, 







Executive Functions As Predictors Of Treatment Outcome in Substance Dependence  
Domain  Study N Measure Substance Effect 
size 










d = 0.58 Less errors on the N-back task was 
significantly related with increased 












Cocaine  d = 0.12 No effect Treatment 
retention 




Alcohol  d = 1.13 Relapsed participants had poorer 
performance on the Alpha-span task 
















Cocaine  r = -0.46 There was a moderate negative 
correlation found between treatment 
retention and the Stroop effect for 









Cocaine r = 0.10 Patients performance on Stroop 
inhibition was significantly 














Cocaine d = 0.01 No effect Treatment 
retention 











d = 0.13 No effect Treatment 
retention 







Cocaine d = 0.02 Higher Stroop Colour-Word T-score 
predicted better treatment adherence 
Treatment 
retention 







Cocaine r =0.78 The Stroop effect was positively 
associated with the number of self-
reported days of abstinence during 










Cocaine  d = 0.19 No effect Treatment 
retention 




Alcohol d = 0.24 Poor GNG response inhibition 






 Passetti et al. 
(2011) 
 
80 Go/no-go Opiates d = 0.27 No effect  Relapse 




Alcohol d = 1.01 At two months follow-up, relapsers 
had higher overall error scores than 











Opiates  d = 0.23 No effect  Relapse 





Alcohol d = 0.71 Poor performance on GNG predicted 






















d = 0.88 Participants who dropped out of 
treatment had lower total scores; 
higher selections from high reward-
high risk decks and lower selections 
from low reward low risk decks, 
compared to participants who 












Opiates d =0.11 No effect  Relapse 








d = 0.69 Poorer performance on the task 











Alcohol  r = -0.54 Strong inverse correlation between 















d =0.15 No effect  Treatment 
retention 










d = 0.67 Poorer performance was predictive 










Cannabis  d = 0.16 No effect; Cannabis abstinence was 
unrelated to cognitive flexibility  
Relapse 





Cocaine  d = 0.83 Steeper delayed discounting was 
significantly associated with shorter 
durations of cocaine abstinence 
Relapse 







 Despite the discrepancies in the literature, it is claimed that deficits in EF can limit 
successful treatment outcomes for individuals suffering from substance dependence (Day et al., 
2015). This is supported by the findings in Table 1, illustrating that EF deficits can be associated 
with poor therapeutic retention rates and greater likelihood of relapse. A potential mechanism 
explaining this association is that the treatments currently implemented in substance dependence 
require high cognitive engagement and involve individuals to perform complex mental processes 
(Perry & Lawrence, 2017). These treatments commonly require substance-dependent individuals 
to implement behavioural change (i.e., leaving the room when presented with cues that elicit 
drug cravings) and modify dysfunctional thinking (i.e., challenge negative thinking that is 
triggered by drug cravings) (Sofuoglu, DeVito, Waters, & Carroll, 2013). However, many of the 
cognitive processes needed for success in these treatments are the very cognitive domains that 
are impaired in substance use (Day et al., 2015). Resultantly, the cognitive and behavioural 
changes that are necessary for abstinence are unable to be initiated and maintained, therefore 
further perpetuating the vicious cycle of addiction (Perry & Lawrence, 2017).  
Inhibitory Control in Substance Use 
 The capacity to delay, disrupt or withhold a behavioural reaction is a critical component 
of EF (Rey-Mermet & Gade, 2018). Inhibitory control (IC) is the ability to inhibit a prepotent 
response, instead utilising a response that is more appropriate or desirable (Diamond, 2013). For 
example, imagine you are driving along the highway and you need to change lanes to overtake a 
car in front of you. As you start to change lanes you suddenly see that there is a car in your blind 
spot; your automatic response would be to continue switching lanes, but your ability to inhibit 
that response, and stay within the same lane, is what is referred to as you IC. IC can be measured 




Go/no-go (GNG) task are the most consistently used measures of IC in research (Spinola, 
Maisto, White, & Huddleson, 2017).  
In the context of addiction, IC is crucial in the ability to resist and impede habitual 
substance use once established (i.e., resist drug-taking behaviour in response to drug cravings) 
(Day et al., 2015). As such, dysfunction in IC is argued to contribute to the development and 
preservation of substance use through an inability to restrain maladaptive drug-seeking 
behaviours (Moeller, Bederson, Alia-Klein, & Goldstein, 2016). Consequently, poor IC is argued 
to contribute to an individual’s vulnerability to addiction (Koob & Volkow, 2016).  
Meta-analytic evidence and systematic reviews have demonstrated that impairments in IC 
are well-established in substance use and dependence (Luijten et al., 2014; Stavro et al., 2013; 
Wright, Lipszyc, Dupuis, Thayapararajah, & Schachar, 2014). Despite the varying 
neurochemical profiles of addictive substances, the abundance of literature suggesting an IC 
deficit in substance use/dependence indicates that IC dysfunction is a reliable defining feature of 
addiction (Table 3) (Charles-Walsh, Furlong, Munro, & Hester, 2014b). This is supported by a 
comprehensive meta-analysis of 97 studies examining inhibition in substance use, which found 
that deficits in IC were apparent for heavy use/dependence on methamphetamine (g=0.72), 
MDMA (g=0.35), cocaine (g=0.47), tobacco (g=0.25), and alcohol (g=0.53) (Smith et al., 2014). 
However, no IC deficit was found for dependence on cannabis (g=0.01) or opiates (g=0.06) 






Measures of Inhibitory Control  
Task Description  Main 
Dependent 








A simple task is performed (i.e. pressing a 
button if the letter M is presented), unless a 
no-go stimulus is presented (i.e., the letter X) 
where participants have to withhold their 
response.  
 
Error rates Automatic 
inhibition 








Task (SST)  
An ongoing task is performed (i.e., pressing 
a button if a X is presented and pressing a 
button if a O is presented), unless a stop 
signal (i.e., two red lines) appear where 
participants have to withhold their response. 
The time between the stop signal and 
presentation of the stimulus is manipulated 
so that participants should only successfully 
withhold their response when a stop signal is 
presented in 50% of trials. The better 
participants perform, the longer the delay is 
between the presentation stimulus and the 

















The task consists of two sets of fifteen 
sentences. In each sentence the last word of 
the sentence is missing. In the first set of 










aloud and the participant simply responds 
with the word that would complete the 
sentence. In the second set of sentences the 
same procedure occurs, however, the 
participant respond with a word (i.e., that 
would not appropriately complete the 








IMT: Participants are presented a sequence 
of five-digit numbers (i.e., 53723) on a 
computer screen, one at a time. Participants 
are required to respond when two identical 
numbers are presented in sequence. 
Numbers may be presented in three forms: 
target stimulus (i.e., five-digit number is 
identical to the preceding five-digit number); 
catch stimulus (i.e., five-digit number differs 
from the preceding five-digit number by 
only one digit); filler stimulus (i.e., random 
five-digit number).  
 
DMT: A sequence of distractor numbers 
(i.e., five-digit numbers) are presented in-
between each five-digit number that is 
required to be compared to the previous in 
the sequence. Participants are required to 
ignore these distractor numbers and 
complete the task as per the IMT.   















The colour of a word is printed in a 
congruent colour (i.e., the word yellow is 
printed in the colour yellow) or incongruent 
colour (i.e., the word yellow is printed in the 
colour blue). Participants are required to 
name the colour of the ink that the word is 







Â Nil to $$$ Norms in 
specialist 
tests; kit is 
restricted 
(C)b 
Flankers Participants are required to respond to a 
central stimulus (i.e., arrow or letter) while 
ignoring flanking stimuli. Flanking stimuli 
may be congruent (i.e., MMM) or 
incongruent (i.e., TMT).  
 
Error rates Ignore 
response 
interference 










Test - III 
Participants press the space bar when they 
are presented with any letter apart from the 
letter X. Participants are required to withhold 
their response when they are presented with 
the letter X.  
 
Error rates Automatic 
inhibition 
ÂÂ $$$$ Restricted 
(B) for 
normsa 
Simon Task  Participants are required to respond to visual 
stimuli (i.e., pressing the right button if a 
circle is presented or pressing the left button 
if a square is presented). The stimuli are 
presented on  either the right or left hand 
side of the screen, which can be congruent 
(i.e., stimuli presented on the right hand side 
















pressed) or incongruent (stimuli presented 
on the left side of the screen and the right 
button must be pressed).   
 
Antisaccade  Participants are required to fixate on a 
stationary (i.e., small dot). A stimulus will 
then be presented on either the right or left 
side of that stimulus. Participants are 
required to make a saccade (i.e., quickly 
move both eyes) in the direction away from 
the stimulus (i.e., if a stimulus was presented 
on the right side of the fixation dot 
participants would be required to move their 
eyes towards the left.  
 
Error rates Ignore 
response 
interference 






Participants respond to an arrow stimulus by 
pressing a button (i.e., left or right) that 
corresponds with the direction that the arrow 
stimulus is pointing. Participants are 
required to respond as quickly as possible, 
unless an auditory signal (i.e., beep) occurs, 
where participants have to withhold their 
response. The time between the stop signal 
and presentation of the stimulus is 
manipulated so that participants should only 
successfully withhold their response when a 
stop signal is presented in 50% of trials. The 











delay is between the presentation stimulus 
and the stop signal.    
Note. One clock = <10 mins; two clocks = >10 mins; dollar value: each $ = a zero (i.e. 300 = $$$; 1100 = $$$$).  
aRestricted (B) = Use is restricted to Allied Health or Special Education Professionals. This restriction also applies to, but is not 
limited to Undergraduate and Master’s degrees in speech pathology, occupational therapy, physiotherapy and may include special 
education, medical and behavioural science 
bRestricted (C) = Use is restricted to Registered Psychologists; Controlled inhibition = response needs to be inhibited after its 









  The ANA suggests that EF deficits are central to the cognitive processes occurring in 
people who are experiencing substance use disorder (Kwako et al., 2016). Despite this, Smith et 
al.’s (2014) meta-analysis found an in-substantial effect of an IC deficit for some classes of 
drugs; cannabis and opiates. A potential mechanism explaining this could be that different 
addictive substances have particular neuromodulator properties that produce relatively stronger 
or weaker impairments in specific EF domains, due to the precise brain regions they target 
(Jovanovski et al., 2005). Both cannabis and opiates have been shown to produce their effects 
through similar processes; through secondary modulation of dopamine via the opioid system in 
the reward pathway compared to the direct dopaminergic effects of cocaine and 
methamphetamine (Fernandez-Serrano, Perez-Garcia, & Verdejo-Garcia, 2011). Hence, the 
comparable neuromodulator properties of these substances could explain why a lack of IC 
impairment was found in Smith et al.’s (2014) meta-analysis, suggesting that IC is not a primary 
deficit of cannabis and opiates.   
However, on closer review of Smith et al.’s (2014) meta-analysis it is apparent that there 
is a dearth of research investigating IC deficits in opiate users. Only five studies were included in 
the present meta-analysis, with four out of the five studies containing small user group sample 
sizes (n<32) (Constantinou et al., 2010; Forman et al., 2004; Fu et al., 2008; Yang et al., 2009). It 
also is apparent that these studies included no, or only a small proportion of female opiate users, 
suggesting that the effect found could be sex-specific rather than applying generally to opiate 
users. Although Smith et al. (2014) included a larger proportion of studies that investigated IC in 
cannabis-dependent individuals (N=11), the majority of these studies also included small user 
group sample sizes, with varying proportions of female inclusion. It is possible that the small 




power to detect small to moderate effect sizes, meaning there is a potential that effects have been 
missed (Smith et al., 2014). 
Dysfunctions in IC have also been claimed to be associated with more frequent use, 
larger dosages, and more failed attempts to reduce and control use (Weafer & Fillmore, 2008). 
Consequently, impaired IC is argued to be predictive of impulsive behaviour and risk of relapse 
in substance use disorders (Dominguez-Salas et al., 2016). Table 1 illustrates the predictive 
outcomes of IC in substance dependence. It is clearly evident that dysfunctions in IC predict poor 
treatment efficacy (Thoma et al., 2011), treatment retention (Wilcox, Dekonenko, Mayer, 







Studies of Substance Use Investigating Inhibitory Control Performance  




Measure Effect size Main findings 
Cocaine Pike, Stoops, 
Fillmore, and 
Rush (2013) 





d = 0.84 Participants allocated to the 
cocaine image condition produced 
significantly more inhibitory 
errors on the no-go targets 
compared to participants allocated 
to the neutral cue condition  
 
 Zhang, Hu, 
Bednarski, 
Erdman, and Li 
(2014) 
 
35 0 Dependent Stop Signal 
Task 
g = 0.47 Cocaine dependent patients had 
longer SSRT compared to 
controls 




27 11 Abstinent Go/no-go Task g = 0.05 No effect 
Methamph
etamine 
Tabibnia et al. 
(2011) 
43 44 Dependent Stop Signal 
Task 
g = 0.65 Methamphetamine dependent-
participants had worse response 
inhibition (prolonged SSRT) 




Xu, and London 
(2005) 
11 36 Dependent Stop Signal 
Task 
g = 1.53 Methamphetamine dependent-
participants had worse response 
inhibition (prolonged SSRT) 









19 11 Dependent Go/no-go Task g = 0.58 Methamphetamine dependent-
participants made more 
commission errors compared to 
controls 
 





37 30 Dependent Stop Signal 
Task 
d = 0.03 No effect; there was no difference 
in SSRT between nicotine-
dependent individuals and 




et al. (2014a) 
 
22 50 Dependent Stop Signal 
Task 
d = 0.97 Inhibitory control performance 
was significantly poorer following 







33 36 Dependent 
and abstinent 
Go/no-go Task g = 0.96 Current smokers had poorer 
response inhibition compared to 
controls and ex-smokers 
Opiates Constantinou et 
al. (2010) 
 
32 38 Dependent 
and abstinent 
Go/no-go Task d = 0.34 No effect 




0 Abstinent Stop Signal 
Task 
d = 1.46 Opiate dependent participants had 
prolonged SSRT compared to 
controls 
 
Alcohol Salgado et al. 
(2009) 




g = 0.87 Alcohol dependent patients made 
more commission errors 
compared to controls 
 
 Czapla et al. 
(2016) 
94 19 Dependent Go/no-go Task d = 0.54 Alcohol-dependent participants 




commission errors compared to 
controls  
 
Cannabis Jutras-Aswad et 
al. (2012) 
 
50 26 Dependent Stop Signal 
Task 
g = 0.25 No effect  














20 50 Regular users Go/no-go Task d = 0.44 No effect; response inhibition did 
not significantly differ between 
MDMA users and drug naïve 
controls 
 
 Roberts and 
Garavan (2010) 
20 50 Regular users Go/no-go Task g = 0.01 No effect 








Inhibitory Control and Alcohol Use 
 Some substances produce impairments in EF acutely as well as chronically. Alcohol is a 
good example of this. It is claimed that alcohol disrupts functioning of the prefrontal cortex, 
producing disinhibiting effects on behaviour, which can lead to impulsivity (Weafer & Fillmore, 
2008). Resultantly, alcohol’s disinhibiting effects produce dysfunctions in IC, causing a reduced 
ability to inhibit maladaptive behaviour (Day et al., 2015). This is thought to facilitate alcohol’s 
abuse potential through binge-drinking, as urges to drink are unable to be inhibited (Weafer & 
Fillmore, 2012).  
 Zoethout, Delgado, Ippel, Dahan, and Van Gerven (2011) claim that IC is a useful 
functional biomarker of acute alcohol intoxication. The disinhibiting effects of alcohol on IC are 
well-established, with Table 4 summarising the evidence for this. Despite this, Table 4 also 
illustrates a proportion of studies that have produced null findings. It was found that lower doses 
of alcohol (0.2-0.5 g/kg) were not sufficient to produce impairments in IC function (Dougherty, 
Marsh-Richard, Hatzis, Nouvion, & Mathias, 2008; Volkow et al., 2006). This is supported by 
Zoethout et al. (2011) who illustrated that the current tasks used to measure IC are only primarily 
sensitive to detecting impairment at higher doses of alcohol (>0.8 g/kg), indicating that they are 










The Effects of Alcohol on Inhibitory Control 





















d = 1.25 Alcohol disrupted inhibitory control in 




24 50 Social 
drinkers 
0.65 d = 0.96 When responses were pre-potent, males 
had higher impairment of inhibitory 
control under the influence of alcohol 
compared to females 
 




26 46 Social 
drinkers 
0.65 d = 1.54 Alcohol impaired inhibitory control 
evident by increased p-failures 










0.65 d = 0.68 Inhibitory control was further impaired 
in binge drinkers compared to non-
binge drinkers 
 Weafer and 
Fillmore 
(2008) 
26 46 Social 
drinkers 
0.65 d = 1.01 Greater impairments in inhibitory 
control was associated with increased 














130 26 Dependent n/aa n/ab Alcohol-dependent patients 
demonstrated increased rate of 
commission errors, but not omission 
errors 
 Salgado et 
al. (2009) 
31 16 Dependent n/aa d = 0.87 Alcohol-dependent patients reported 







75 52 Moderate to 
heavy 
drinkers 
0.65 d = 0.29 No effect; this dose of alcohol was not 
sufficient to produce impairments in 













d = 0.04 No effect; inhibitory control 
performance was not significantly 




et al. (2008) 
90 50 Social 
drinkers 
0.2, 0.4, 0.6 
and 0.8 
n/ab No effect; there was no significant 
difference in inhibitory control between 
peak BrAC and any of the other alcohol 




35 0 Social 
drinkers 












19 0 Social 
drinkers 
0.08% d = 0.34 There was no significant difference in 
SSRT between alcohol and placebo 
conditions 
 
Stroop Task Volkow et 
al. (2006) 
20 40 Moderate 
drinkers 
0.25 and 0.5 0.25:  
d =0.27 
0.5:  
d = 0.19 
 
No effect; these doses of alcohol were 
not sufficient to produce impairments in 
inhibitory control 
 Schweizer 
et al. (2005) 




d = 0.90 
BrAC 
descending: 
d = 1.02 
 
Participants in the alcohol group had 
increased response times on the BrAC 
ascending limb and also made more 
















n/aa d = 0.66 Heavy drinkers had poorer inhibitory 






24 54 Abstinent n/aa d = 0.90 Alcohol-dependent participants 
demonstrated poorer inhibitory control 




Note. n and % of females includes only substance taking/abstinent participants and does not include controls; BrAC = breath alcohol 
concentration; SSRT = stop signal reaction time.  
an/a: participants were not under the influence of alcohol at the time of testing; n/ab: effect size was unable to be calculated due to the 








 Dry, Burns, 
Nettelbeck, 
Farquharson
, and White 
(2012) 





d = 1.06 
0.10%: 
d = 1.06 
Participants in the alcohol condition 
made significantly more errors of 
commission at both 0.05% and 0.10% 






Conversely, Table 4 also illustrates a portion of studies that have demonstrated no IC 
deficit even at moderate to high doses of alcohol (0.6-0.8 g/kg) (Dougherty et al., 2008; Spinola 
et al., 2017), with Guillot et al. (2010) demonstrating that BrAC of 0.1% produced no significant 
impairments in IC. On closer review, Table 4 shows that the studies which have produced null 
findings at higher alcohol doses all measured IC using the SST. This suggests that the SST may 
lack sensitivity to detect IC deficits under acute alcohol impairment. Spinola et al. (2017) 
supports this, claiming that the disparity in the literature could be due to the differences in the 
sensitivity of IC measures used.  
Wright et al. (2014) claim that the SST and GNG task measure distinctive aspects of IC. 
As illustrated in Table 2, the SST is claimed to measure controlled inhibition, where a response 
needs to be inhibited after its initiation (Littman & Takacs, 2017); and the GNG task which is 
claimed to measure automatic inhibition, where a prepared response that has not been initiated is 
withheld (Smith et al., 2014). Wright et al. (2014) suggests that cancellation of an already 
initiated response is more cognitively demanding and requires higher EFs than withholding a 
planned response which has not been initiated. This could account for why moderate doses of 
alcohol impair IC measured with the GNG tasks but not SSTs, indicating that the GNG task may 
be a more sensitive to acute impairments from alcohol. This is supported by research 
investigating IC impairment at moderate alcohol doses (0.65 g/kg) in social drinkers, illustrating 
that IC is further impaired using the GNG task (d=0.85), compared to the SST (d=0.52) (Birak, 
Higgs, & Terry, 2011). Despite Birak et al.’s (2011) small sample size (N=24), meta-analytic 
evidence further supports this, demonstrating that the weighted mean effect size for alcohol 





Inhibitory Control and Working Memory 
 Deficits in IC have been argued to be associated with impairments in other cognitive 
domains as a result of neuroadaptations from chronic substance consumption (Day et al., 2015). 
As previously discussed, EF is claimed to be composed of three fundamental domains; IC, WM 
and cognitive flexibility (Figure 2) (Diamond, 2013). It has been consistently demonstrated that 
there are moderate to strong magnitude correlations between IC and WM (Chambers, Garavan, 
& Bellgrove, 2009; Hester & Garavan, 2004; Looby, Norton-Baker, & Russell, 2018), 
suggesting that IC and WM contain a substantial proportion of common variance. This is further 
supported by Miyake et al.’s (2000) confirmatory factor analysis of EFs, where a positive, strong 
relationship between IC and WM was found (r=.63, 95% CI [.09, .76]). 
 
 
Figure 2. Model of Executive Functioning adapted from Miyake et al. (2000).  
  
 Engle, Conway, Tuholski, and Shisler (2016) claim that EF processes run on a limited 
reserve. This is explained by the limited resource model of executive functioning, which 




their WM capacity is taxed or exhausted (Looby et al., 2018). Subsequently, it is claimed that if 
WM is taxed or exhausted, the ability to inhibit impulsive behaviour and distractions is also 
limited (Looby et al., 2018). This is argued to be a result of actively maintaining your goal in 
mind to identify what will facilitate or hinder the achievement of that goal and what may need to 
be inhibited (Diamond, 2013). Hence, a deficit in either WM or IC produce subsequent 
impairments in each other (Hester & Garavan, 2004), indicating that these two constructs 
simultaneously support each other (Diamond, 2013). Despite this, debate still exists around 
whether IC and WM are in fact separate cognitive processes or part of an integrated system 
(Friedman & Miyake, 2004; Noel et al., 2013). 
Developing a New Task of Inhibitory Control: Whack-a-Bottle 
 Neuroscience-based frameworks; such as the ANA and Impaired Response Inhibition and 
Salience Attribution (iRISA) model of substance use disorder, as well as the broader Research 
Domain Criteria Initiative (RDoC), Cognitive Neuroscience Treatment Research to Improve 
Cognition in Schizophrenia (CNTRICS) and the National Institute of Mental Health’s consensus 
measures for Phenotypes and eXposures (PhenX), emphasise the importance of assessing EFs as 
a predictor of functional outcome (Kwako et al., 2016). Specifically, they all include the 
assessment of IC, with general consensus indicating that the SST and GNG task are gold 
standard measures (Table 5).  
Workforce surveys have indicated a strong interest in assessment of IC during substance 
use treatment (Collins, 2018). However, these are poorly utilised due to current, valid measures 
of IC being expensive, restricted and not accessible to frontline workers (Table 2) (Day et al., 
2015). These measures are also tedious to complete, have poor appeal to participants, and are 






Neuroscience-based Assessment Frameworks and Tasks of Inhibitory Control 
Neuroscience-based Assessment Frameworks Description Tasks of Inhibitory Control 
Addictions Neuroclinical Assessment (ANA) The ANA is a neuroscience-based framework 
for addictive disorders that encompasses three 
functional domains that are derived from the 
neurocirculatory of addiction; incentive 





Impaired Response Inhibition and Salience 
Attribution (iRISA) 
The iRISA is a neuroscience-based framework 
that identifies the disruptions in the 
neurocirculatory of addiction and emphasises 
the importance of inhibitory control in the 




§ Stroop Task  
 
Research Domain Criteria Initiative (RDoC) RDoc is a research framework that focuses on 







Cognitive Neuroscience Treatment Research 
to Improve Cognition in Schizophrenia 
(CNTRICS) 
 
CNTRICS is a neuroscience-based framework 
with the primary goal of developing 
measurements that can be implemented in 
treatments to improved impaired cognition in 
schizophrenia.   
§ SST 





PhenX Toolkit PhenX Toolkit is an online catalogue of 
standardised measures that have been 
developed for a variety of domains. It includes 
a group of measures that focus on the 
assessment of substance dependence and abuse. 
   
§ SST 
§ GNG 
















 Recently, a ‘serious games’ movement has emerged, aiming to develop engaging tools 
for cognitive assessment. ‘Serious games’ promote users to interact at a deeper level with a 
cognitive test through novel engagement and motivational properties (i.e., receiving/losing 
points) typically used in recreational computer games (Connolly, Boyle, MacArthur, Hainey, & 
Boyle, 2012). Hence, putting neuropsychologically informed tests within this framework fosters 
engagement and improves the attractiveness of the cognitive measures. Consequently, we have 
developed a brief, interactive IC task for smartphones and tablets based on a ‘serious games’ 
approach to enhance user engagement.  
Our proposed measure of IC is based on a whack-a-mole concept; a version of a GNG 
paradigm and is subsequently named ‘Whack-a-Bottle’ (WAB) (Figure 3). Instead of moles, go-
stimuli are bottles of healthy drinks (water, orange juice) and no-go stimuli are bottles of 
alcoholic drinks (beer, wine), which appear randomly, one at a time. The simple and random 
nature of the task safeguards the WAB’s susceptibility to learning effects as strategy generation 
is limited. Additionally, the WAB’s software is compatible with most Android devices, allowing 
it to be portable and easily accessible. Our goal is to make the WAB freely available to clinicians 





Figure 3. Whack-a-Bottle. Alcoholic and non-alcoholic bottles represent go and no-go targets, 
respectively.  
 
Since impaired IC is a defining feature of substance use and dependence (Table 3), the 
use of alcoholic no-go stimuli in the WAB was implemented to foster inhibitory control training 
(ICT) in substance consuming populations. ICT aims to strengthen IC through repeated 
inhibition of a prepotent response to salient stimuli (Luijten et al., 2014). Houben, Nederkoorn, 
Wiers, and Jansen (2011) have demonstrated that significant reductions in weekly alcohol intake 
were found when heavy drinkers were trained to inhibit alcohol-related no-go stimuli, compared 
to when alcohol-related stimuli were paired with the go condition in a modified beer-GNG task. 
In addition, recent meta-analytic evidence has illustrated moderate reductions in alcohol 




that reductions in harmful behaviours (i.e., alcohol consumption) were larger for GNG training 
(d=0.50), compared to SST training (d=0.26), further supporting the findings that the GNG task 
is a more sensitive measure of IC (Allom, Mullan, & Hagger, 2016). 
 The primary aim of this study is to validate the WAB against traditional, gold standard 
measures to determine whether it is a valid and sensitive measure of IC. Due to the WAB being 
based on a GNG paradigm, it is hypothesised that the task will demonstrate strong correlations 
with traditional measures of IC. Specifically, it is hypothesised that the WAB will demonstrate 
large magnitude correlations with the SST and Flanker GNG task. As IC and WM are claimed to 
have a substantial proportion of common variance (Miyake et al., 2000), it is further 
hypothesised that the WAB, and other tasks of IC, will demonstrate convergent validity, in that 
they will establish moderate magnitude correlations with other executive tasks of WM. 
Additionally, due to the random nature of the task, it is also hypothesised that the WAB will 
produce minimal learning effects in a repeated measures context. Since the WAB has been 
specifically developed for substance consuming populations, study two aims to test the effects of 
acute alcohol intoxication on IC. On the basis of previous findings (Table 4), it is hypothesised 
that if the WAB is a valid measure of IC, then it should be sensitive to impairment from alcohol. 
 Method: Study One 
Study one investigated whether the WAB is a valid measure of IC, and stable over 
repeated assessment.  
Participants 
 The current study recruited 68 participants (28 males) (Mage=41.1, SD=13.7, range=20-
64) from the general community through social media. Participants were deliberately stratified 




across the age range where the WAB is hoped to be applied (adult substance use treatment, 
where 75% of clients are in the 20-49 age range (Australian Institute of Health and Welfare, 
2019). Eligibility criteria included English as a primary language, age between 20-64, and 
normal or corrected-to-normal vision. Exclusion criteria included current mental health problems 
(i.e. self-report), major physical health problems, and prescribed current sedating psychoactive 
medication. Participants were reimbursed $10 per testing session ($20 total) for their time.  
Materials 
Inhibitory control measures. Whack-a-Bottle (WAB). This is a GNG task adapted from 
a whack-a-mole game. Instead of moles, go-stimuli are bottles of healthy drinks (water, orange 
juice) and no-go stimuli are bottles of alcohol (beer, wine). The aim of the game is to ‘hit’ the 
healthy drinks and avoid hitting the alcoholic drinks. There are 100 trials, with 1.2 seconds per 
each trial, with an 84% probability of a drink presented being a ‘go’ stimuli (i.e., stimuli 
requiring a response) and 16% probability of an alcoholic drink (stimuli requiring response to be 
withheld). There are 50ms between trials. Two primary measures of IC were utilised; percent of 
IC errors and score (participants are given 10 points per correct ‘go’ response within 1200ms, 
and an additional 5 points if responses are made within 500ms of stimuli onset; participants are 
penalised 100 points for every no-go response; scores are displayed on-screen). Score is another 
way of measuring IC that takes into consideration reaction time and errors, hence it may capture 
speed/accuracy trade-offs. 
Flanker Task (GNG). In this task, stimuli consist of five arrows with a central target 
arrow pointing left or right flanked on both sides either by two squares (neutral), two arrows 
pointing in the same direction (congruent), or opposite direction (incongruent). Participants 




or 1000ms has elapsed. Congruent, neutral, and incongruent trials each comprise 30% of 80 total 
trials. On 10% of trials a NoGo trial occurs, where suppressor flankers (‘X’) indicate to withhold 
a response. The outcome measure was the number of IC errors on No Go trials.  
 
 
Figure 4. Example targets from the Flanker GNG Task. In all cases participants need to respond 
by determining if the central arrow points to the left or the right. The surrounding stimuli might 
be congruently pointing arrows, incongruently pointing arrows, or neutral stimuli (squares). 
When the surrounding stimuli are Xs, the participant has to not respond.  
 
Stop Signal Task. Following 500ms presentation of a central fixation point, participants 
press a left or right square as fast as possible when ‘X’ or ‘O’ (go signal – stimuli a and b in the 
figure below). Stop-signal trials, requiring withholding of response, consist of a stimulus (two 
red lines) that initially occurs 250ms after letter onset (termed stop-signal delay (SSD)). SSD 
increased 50ms following failure to inhibit and decreased by 50ms following correct inhibition. 
There are 48 trials (25% stop-signal). Stop Signal Reaction Time (SSRT) is estimated by 




variables was SSRT in ms.  
 
 
Figure 5. Example stimuli in the Stop Signal Task. Participants need to press one button if they 
see a X on the screen (a) or a different button if they see a O on the screen (b) as quickly as 
possible. On a small number of trials, a few milliseconds after the X or O appear, two red lines 
will appear. In these cases the participant will need to not respond.  
 
Working memory measure (convergent validity). N-back Task. Participants are 
presented a sequence of letter stimuli one at a time, at a rate of one per second. For each 
stimulus, they need to decide if the current stimulus is the same as the one presented N trials ago. 
Participants completed a 1, 2, and 3-back version of the task in sequence. There were 12 targets 
in the 1-back task; and 24 targets in the 2- and 3-back tasks, with targets randomly presented at a 






Figure 6. Example of the N-back task. In each level of difficulty of the task, letters are displayed 
on screen one at a time, one per second. In the easiest version (1-back) participants have to 
respond whenever the new letter is the same as the one they saw 1 stimuli previously (i.e., they 
would press the button the second time the R was presented in the orange list above). In more 
difficult versions, the participants need to press a button whenever the new stimuli match the one 
presented 2- (or more) ‘back’. For example, in the 2-back level of difficulty, in the orange 
sequence above, participants would respond to the second X.  
 
Covariate. Wechsler Test of Adult Reading (WTAR). The WTAR is a series of 50 words 
that have irregular grapheme-to-phoneme correspondence. Participants are asked to read aloud a 
list of words; correctness of pronunciation is recorded. The scale is co-normed with the Wechsler 
Adult Intelligence Scale and provides a brief estimate of verbal intelligence (r=0.75 with WAIS 
Verbal IQ) (Wechsler, 2001).  
User Experience Questionnaire (short form). The short version of the User Experience 
Questionnaire (UEQ-S) was included to gather subjective consumer opinions towards the user 




UEQ-S includes two scales; pragmatic quality (i.e., usability/functionality; 4 items) and hedonic 
quality (i.e., engagement/enjoyment; 4 items). Each item is measured using a seven-level 
semantic differential (two terms with polar opposite meanings at low and high anchors). The 
scale has normative data from instruments such as businesses software, web services and social 
media, from over 280 studies of software user experience reports. 
Procedure 
The University of Tasmania Social Science Human Research Ethics Committee approved 
the project (Approval #H0018073: Appendix A). Eligible participants (Appendix B) completed 
two 30-45 minute sessions, conducted approximately seven days apart (minimum of 5, maximum 
14 days); informed consent was received in session one (Appendix C and D). To control for 
diurnal variability, the second session was conducted at approximately the same time of day. 
Prior to commencement of the cognitive test battery, the cognitive tests were explained both 
verbally and using instruction sheets; a demographic survey (Appendix E) was also completed. 
The cognitive test battery was standardised between sessions, with the cognitive tests 
administered in the following order: (1) WTAR (first session only); (2) WAB; (3) Flanker GNG; 
(4) N-back; (5) SST. The second session also administered the UEQ-S after completion of both 
the WAB and the SST to determine participant acceptability of each task. All cognitive tasks 
were completed on a 7” Android tablet. 
Design and Analysis  
Technical malfunction resulted in demographic, UEQ-S and session one WAB data to not 
be recorded for one participant. To assess construct validity, a correlational approach was 
adopted, assessing cross-sectional relationships between the measures. Three different measures 




Five continuous dependent variables (DVs) were utilised (percent of IC errors and score on the 
WAB; number of IC errors on Flanker GNG; SSRT on the SST; % correct on the N-back). 
Baseline correlations between the WAB and the other two validated measures IC were used to 
test the hypothesis that the WAB will demonstrate strong construct validity. Likewise, baseline 
correlations between the IC tasks and a measure of WM (N-back) tested the hypothesis that the 
WAB correlates with other processes known to relate to the IC construct.  
Correlations between test and retest for each cognitive measure was also utilised to assess 
for consistency across assessment time points. These were assessed using correlation analyses 
and were interpreted using Pearson’s correlation coefficient (r); +/-0-0.10=trivial, +/-0.10-
0.29=weak, +/-0.30-0.49=moderate, +/-0.50-1.00=strong (Akoglu, 2018). Learning effects on 
repeat testing was assessed using paired samples t-tests to determine significant differences 
between test and retest for the cognitive measures as well as calculating effect sizes. Bayes 
factors were also used to determine the evidence in favour of the null hypotheses. Paired samples 
t-tests were used to assess significant differences between user experience for the SST and 
WAB. Statistical analyses were conducted on JAMOVI v1.1.3.0. Effect sizes were interpreted as 
0.2=small, 0.5=moderate, 0.8=large (Cohen, 1992).  
Results: Study One 
Sample Characteristics  
 The sample comprised of adults across the age range with average levels of intellectual 
functioning and high levels of education (Table 6). The sample had low levels of gaming 
experience in the past week, with 46% not spending any time on games, indicating that it is 






Demographic Characteristics (N=67) 
Sample Characteristic  Mean (SD) Range 
Age 41.1 (13.7) 20.8 – 63.8 
% Males 41%  




Frequencies   
Males Females 
 








20.8 – 28.8 
30 – 39 2 8 35.3 (2.61) 31.3 – 38.8 
40 – 49 5 10 44.8 (2.79) 40.6 – 49.4 
50 – 59 8 9 56.0 (2.65) 50.9 – 59.9 
60 – 64 2 2 61.4 (2.05) 60.1 – 63.8 
 
Intellectual functioning (WTAR)a  112.0 (7.53) 87.0 – 124.0 
Gaming (hours per week)  2.8 (4.61) 0.00 – 20.0 
Note. Mean age is not representative because ten participants did not correctly fill out their 
specific age on the demographic questionnaire. However, age group data was completed for all 
participants.  
aWechsler Test of Adult Reading (WTAR); standardised score is 100 and scores are normed 




Recruitment was stratified across the age-range to provide normative data for 












Normative Data for Score and Percent of Inhibitory Control Errors on Whack-a-Bottle 
Whack-a-Bottle Measures 
 Score  Percent of Inhibitory Control Errors 
 n Mean SD  n Mean SD 
Age-groups 
 
       
20-29        
Males 11 1886 901  11 0.12 0.12 
Females 11 1385 558  11 0.12 0.12 
30-39        
Males 2 1140 226  2 0.04 0.05 
Females 8 998 140  8 0.02 0.04 
40-49        
Males 5 1404 646  5 0.03 0.05 
Females 10 1113 446  10 0.04 0.04 
50-59        
Males 8 786 62.8  8 0.02 0.03 
Females 9 819 106  9 0.02 0.04 
60-64        
Males 2 685 332  2 0.22 0.12 
Females 2 850 28.3  2 0.00 0.00 





Whack-a-Bottle. Percent correct on the WAB was used to assess the validity of the task. 
Across both test and retest, the mean performance of participants was above 95%, indicating that 
participants performed the task correctly (Table 8). 
Stop Signal Task. The SST uses a staircase procedure to modify SSD following correct 
performance and requires the proportion of IC errors to be close to 50% for accurate calculation 
of the SSRT. Across both test and retest, the percent of responses remained above 50%, 
indicating that delayed responses on the SST did not interfere with the validity of the SSRT 
results (Table 8).  
 
Table 8 
Mean (SD) Performance of Percent Correct on Whack-a-Bottle and Percent of Responses on the 
Stop Signal Task  
Manipulation Checks Test Retest 
 Mean (SD) Mean (SD) 
Whack-a-Bottle:  
 






Stop Signal Task: 
 






Note. Mean and SDs represented as percentages. 
 
Correlations 
 Does the Whack-a-Bottle Task correlate well with traditional measures of inhibitory 




errors on the WAB and Flanker GNG task were seen at both test (r=0.16) and retest (r=0.01; 
Table 9). Significant, moderate magnitude inverse correlations were found between WAB IC 
errors and SSRT at test (r=-0.31) and retest (r=-0.45). Using the more global measure of WAB 
score, there was a positive, small non-significant relationship with IC errors on the Flanker GNG 
task at test (r=0.12), falling to trivial and inverse on retest (r=-0.03). Significant, moderate 
inverse correlations were found between global WAB score and SSRT at test (r=-0.37) and retest 
(r=-0.36). In contrast, IC errors on the Flanker GNG task had significant but weak relationships 
with SSRT at test (r=-0.26), falling to trivial and non-significant at retest (r=-0.02). 
Do measures of inhibitory control correlate with tasks of working memory? There 
were insubstantial relationships between WM performance (percent correct on N-back) and IC 
measures on either the WAB or the Flanker GNG task (r<|0.1|; Table 9). A similar lack of 
relationship was identified between WM performance and SSRT (r<|0.1|). Using the more global 
measure of WAB Score, there was a positive, small significant relationship with WM 





Correlations Between Cognitive Measures 
Cognitive Measures 1. 2. 3. 4. 5. 
1. Whack-a-Bottle score - 0.33** -0.36** -0.03 0.01 
2. Whack-a-Bottle inhibitory control errors 0.35** - -0.45*** 0.01 0.13 
3. Stop Signal Reaction Time -0.37** -0.31* - -0.02 -0.05 
4. Inhibitory control errors Flanker GNG 0.12 0.16 -0.26* - -0.05 
5. N-back Percent Correct 0.25* -0.01 -0.06 -0.05 - 
Note. Correlations for test (baseline) on the lower diagonal; correlations for retest on the upper diagonal. N = 67 for all Whack-a-
Bottle measures due to the baseline measure of one participant to not be recorded; N = 68 for all other cognitive measures. GNG = 
Go/No-go. 




Are Measures of Inhibitory Control Stable Over Time? 1: Test-Retest Correlations.  
Typical acceptable values of test-retest reliability of scales in psychological research has 
been suggested to be 0.7 by Nunnally (1970). As demonstrated in Table 10, IC measures on the 
WAB and the Flanker GNG task fell short of this criterion (r=0.41 and r=0.50 respectively). The 
more global measure of WAB score performed similarly (r=0.53). SSRT, however, performed 
better (r=0.75).  
 
Table 10 
Correlations Between Test and Retest for Measures of Inhibitory Control 
 Test - Retest 
Cognitive Measures r p 
Whack-a-Bottle score 0.53 < .001 
Whack-a-Bottle inhibitory control errors 0.41 < .001 
Stop Signal Reaction Time 0.75 < .001 
Inhibitory control errors Flanker GNG 0.50 < .001 
Note. For all Whack-a-Bottle measures N = 67; for all other cognitive measures N = 68; GNG = 
Go/No-go.  
 
Are Measures of Inhibitory Control Stable Over Time? 2: Learning Effects.  
There were no indications of meaningful learning effects for either WAB IC errors or the 
global score measure, with non-significant, small magnitude increases on both measures (errors: 
d=0.05; score: d=0.17). In addition, Bayes Factors indicated strong evidence in favour of the null 
hypothesis of no change in performance (Table 11). However, examining individual level 




WAB (54% at test; 56% at retest; 34% making no errors at either test or retest).  
 
 
Figure 7. Individual change on retest for the Whack-a-Bottle task. a) score; b) percent of 
inhibitory control errors. Lines represent change on retest; dotted line represents group baseline 
mean; blue dots represent males; red dots represent females. 
 
However, IC errors on the Flanker GNG task demonstrated a statistically significant, 




participants making less IC errors on retest. Bayes factors suggest strong support for a difference 
in performance overtime (Table 11). Examination of individual level change (Figure 8b) 
suggests that the majority of change between test and retest was positive (57%). Only a small 
minority of participants made no IC errors on this task (13% at test; 25% at retest; 1% making no 
errors at either test or retest).  
Conversely, SSRT on the SST demonstrated a statistically significant, moderate 
magnitude reduction in performance between test and retest (d=-0.31), with participants’ 
performance worsening on retest. Additionally, Bayes Factors suggest that there is a reasonable 
evidence to support a difference in reduced performance overtime (Table 11), indicated by a 
Bayes Factor just above 0.3. Examination of individual level change (Figure 8a) suggests that the 






Figure 8. Individual change on retest for the Stop Signal Task and Flanker Go/No-go Task. a) 
stop signal reaction time on the Stop Signal Task; b) number of inhibitory control errors on the 
Go/No-go task. Lines represent change on retest; dotted line represents group baseline mean; 







Descriptive Statistics and Tests of Change in Cognitive Task Performance Over a Seven-Day Retest Period  
Cognitive measure 
 
Test Retest       
 
 




1190.15 (607.78) 1101.48 (446.14) 1.37 66 .177 0.17 3.08 No 
WAB PE 0.06 (0.09) 0.06 (0.08) 0.40 66 .687 
 
0.05 6.90 No 




-2.53 67 .014 -0.31 0.39 Likely 




3.94 67 <.001 0.48 0.01 Yes 




-2.58 67 .012 
 
-0.31 0.35 Likely 
Note. N = 67 for all Whack-a-Bottle measures due to the baseline measure of one participant to not be recorded; N = 68 for all other 
cognitive measures. GNG = Go/No-go; Whack-a-Bottle=WAB; percent of inhibitory control errors = PE; stop signal reaction time = 
SSRT; inhibitory control errors = IC errors; Go/No-go = GNG; percent correct = PC.  




User Experience Questionnaire-Short.  
Participants substantially preferred the WAB to a more traditional assessment of IC (i.e., 
SST) on both pragmatic (d=1.30) and hedonic scales (d=0.52) of the UEQ-S (Table 12). Using 
UEQ norms, mean participant ratings for pragmatic quality for the WAB were in the top 10% of 
results (‘excellent’ range), in the third quartile (50-75%, ‘above average’ range) for hedonic 
quality, and in the second quartile (75-90%, ‘good’ range) for overall rating (Figure 9). 
 
 
Figure 9. Mean scores of the a) Whack-a-Bottle and b) Stop Signal Task in relation to a 
benchmark data set. Error bars represent 95% confidence intervals. Benchmark data set is based 





Paired Samples t-Test Between the Whack-a-Bottle Task and Stop Signal Task on the User Experience Questionnaire - Short 
Comparison 
 
WAB SST    95% CI  
 
 





18.24 (4.85) 9.49 66 <.001 4.09 6.27 1.30 
Hedonic Quality 
 
21.15 (4.12) 18.79 (4.93) 3.66 66 .001 1.07 3.66 0.52 
Overall UEQ 44.57 (6.04) 37.03 (6.12) 7.30 66 <.001 5.48 9.60 1.24 
Note. Pragmatic and Hedonic refer to the two scales on the User Experience Questionnaire – Short Form. WAB = Whack-a-Bottle; 






Method: Study Two 
Study two examined whether the WAB was sensitive to the effects of alcohol 
intoxication.  
Participants 
 The current study recruited 37 participants (22 females) aged between 18-31 years-old 
(M=22.84, SD=3.12) from the general community through social media. Participants were 
reimbursed $50 for their time. Eligibility criteria included: (1) age between 18-31, as individuals 
within this age range are the most likely to binge drink and be susceptible to alcohol-related 
harms (Australian Institue of Health and Welfare, 2017); (2) English as a first language; (3) 
completed high school; (4) normal or corrected-to-normal vision; (5) regular sleeping patterns; 
(6) frequent alcohol consumption to ensure safety of alcohol doses administered (minimum 
consumption of two standard alcoholic beverages on one occasion in the preceding month); (7) 
and body mass index between 18.50 and 31.0 to minimise the differential rate of alcohol abortion 
due to body mass (Foster & Marriott, 2006).  
Participants were excluded from the study for: (1) recent illicit drug use (preceding six 
months); (2) regular tobacco use; (3) history of a significant medical/psychological conditions; 
(4) significant psychological distress (Kessler Psychological Scale; K10 score ³ 30 indicates 
clinical levels of psychological distress) (Kessler et al., 2002); (5) history of alcohol or drug 
abuse or dependence disorder; or use of alcohol at hazardous or harmful levels (Alcohol Use 
Disorder Identification Test score ³ 16  indicates likely alcohol dependence; AUDIT) (Babor, 
Higgins-Biddle, Saunders, & Monteiro, 2001). 
Materials and Apparatus 




utilised. The same standardised order of the cognitive tests was also used for each BrAC target; 
the SST was not administered at BrAC 0.05% ascending to reduce administration time.  
Breath alcohol concentration. Participant’s Breath Alcohol Concentration (BrAC) was 
measured using Andatech AlcoSense Prodigy S police-grade breathalysers. This device meets 
Australian standards; AS3547. 
Procedure 
 The Tasmanian Health and Medical Human Research Ethics Committee approved the 
project (Approval #H0016125: Appendix F). Eligible participants (Appendix G) were asked to 
attend a four-five hour laboratory session, abstaining from alcohol for 24 hours and food for 4 
hours prior to attending. Weight and height were measured and a preliminary breath alcohol 
assessment was conducted to exclude on-arrival intoxication; informed consent was also 
obtained (Appendix H and I). Before commencement of the cognitive test battery, the cognitive 
tests were explained both verbally and using instruction sheets. Participants then undertook the 
cognitive test battery at a BrAC of 0.00%.  
Participants were then administered an alcoholic beverage following National Institute on 
Alcohol Abuse and Alcoholism guidelines (NIAAA, 2004); a combination of vodka, 300mls of 
soda water and 100mls of sugar-free raspberry flavoured syrup. The quantity of alcohol 
administered to each participant was calculated according to the Widmark equation (Figure 10) 
(Dry et al., 2012), allowing for the target of 0.08% BrAC to be reached. Participants were given 
ten minutes to orally consume their alcoholic beverage. They were instructed to avoid retaining 
the beverage in their mouths for longer than five seconds as retention of mouth alcohol can 
influence breathalyser sensitivity (Spector, 1971). Water was used to rinse participant’s mouth 




Immediately after, a post-consumption breath assessment was taken. Breath alcohol 
concentration assessments were completed every ten minutes post-consumption to track 
participants breath alcohol ratings. Participants completed the cognitive test battery at 0.05% 
BrAC, again at 0.08% BrAC on the ascending limb of the alcohol curve, and lastly at 0.05% 
BrAC on the descending limb of the alcohol curve.  
 
Figure 10. Widmark equation used for calculating quantity of alcohol dose required to achieve 
0.08% target breath alcohol concentration based off sex, weight and height of participant (Dry et 
al., 2012).  
 
 Participants were required to stay within the testing facility until they reached three 
consecutive breath alcohol ratings of 0.03% or below (if they held a full drivers licence) or a 
breath alcohol rating of 0.00% (if they held a provisional drivers licence and intended on 
driving).  
Design and Analysis  
Technical malfunction resulted in the data for one participant to not be recorded for the 
SST, Flanker GNG and N-back task. Dependent variables were percent of IC errors and score on 
the WAB; number of IC errors on Flanker GNG; SSRT on the SST; % correct on the N-back. 




estimation (REML) and a diagonal covariance structure were conducted on IBM SPSS v23. 
Target BrAC (0.00%, 0.05% ascending, 0.08% peak, 0.05% descending) was included as a fixed 
and repeated effect. Sex and the interaction between target BrAC and sex were also included as 
fixed effects. ‘Participants’ was included as a random effect to account for intra-individual 
variation. To account for differences in general cognitive function, participants’ WTAR score 
was included as a covariate for all measures. Benjamini-Hochberg adjusted pairwise 
comparisons were used to check for differences in dependent variables across target BrAC. 
Alpha levels were maintained at p < .050. 
The sensitivity of each task to impairments of alcohol was examined by calculating the 
effect sizes for the magnitude of the difference between baseline (0.00 BrAC) and 0.05 BrAC 
ascending and descending; and between baseline (0.00 BrAC) and 0.08 BrAC, for each of the 
three IC measures (WAB; Flanker GNG; SST). Effect sizes were calculated using Hedges’ g, as 
it accounts for the bias in small samples compared to Cohen’s d (Hedges, 1981).  
Results: Study Two 
Sample Characteristics 
 The sample consisted of young adults who reported average levels of intellectual 
functioning, low psychological distress and strong educational background, with all participants 
completing year 12 schooling. All participants were regular drinkers and reported drinking two 









Demographic Characteristics (N=37) 
Sample Characteristic Mean (SD) Range 
Age (years) 22.84 (3.12) 18.0-31.0 
% Male 41%  
Harmful Alcohol Use (AUDIT)a 6.57 (2.80) 1.0-14.0 
Psychological Distress (K10)b 15.03 (3.97) 10.0-28.0 
Intellectual functioning (WTAR)c 113.00 (7.09) 92.0-126.0 
Body Mass Indexd 23.88 (3.13) 18.5-31.2 
Average number of standard drinks in the last fortnight 10.10 (9.50) 2.0-50.0 
Sleep patternse  (hours per weeknight) 





aThe Alcohol Use Disorder Identification Test (AUDIT; Babor et al., 2001) is a measure of 
alcohol dependency. Scores range from 0 – 40, with scores ³ 16 indicative of harmful or 
hazardous alcohol use. bThe Kessler Psychological Scale (K-10) is a measure of psychological 
distress, with scores ranging from 10 – 50. K10 scores ³ 30 indicate clinically significant levels 
of psychological distress. cWechsler Test of Adult Reading (WTAR); standardised score is 100 
and scores are normed based on age. WTAR score <70 is indicative of intellectual functioning 
disorder (Wechsler, 2001). dThe healthy Body Mass Index (BMI) range is between 18.5-24.9; 
scores above 25.0 are considered overweight and above 30 are considered obese (World Health 
Organization, 2019). cHealthy adults require on average 7 – 9 hours sleep per night for normal 
functioning (National Sleep Foundation, 2016). 
 
Breath Alcohol Concentration (BrAC) 
 Since BrAC was zero at baseline, only mean BrAC for each target BrAC post-beverage 
administration was calculated. At each target BrAC, intra-individual variation was observed 
(Figure 11). At the 0.05% ascending target BrAC ‘timepoint’, mean BrAC was 0.057% 
(SD=0.01); 0.075% (SD=0.01) at the 0.08% target BrAC timepoint and 0.049% (SD=0.00) at the 







Figure 11. Mean and individual breath alcohol concentrations (BrAC) attained at each target 
BrAC. Individual lines represent each participant’s attained BrAC at each target BrAC timepoint. 




Whack-a-Bottle. Percent correct on the WAB was used to assess the validity of the task. 
Across each target BrAC, the mean performance of participants was above 96%, indicating that 






Figure 12. Means with 95% confidence intervals for percent correct on the Whack-a-Bottle Task 
at each target breath alcohol concentration (BrAC). 
 
Stop Signal Task. The SST uses a staircase procedure to modify SSD following correct 
performance and requires the proportion of IC errors to be close to 50% for accurate calculation 
of the SSRT. Across each target BrAC, the percent of responses remained above 50%, indicating 







Figure 13. Means with 95% confidence intervals for percent of responses on the Stop Signal 
Task at each target breath alcohol concentration (BrAC). 
 
Inhibitory Control Measures: Sensitivity to Alcohol Intoxication 
Whack-a-Bottle. There were statistically significant main effects of target BrAC for both 
IC errors and the overall global score (Table 14), indicating that alcohol intoxication influenced 
performance on these measures. A significant main effect of sex was found only for WAB score 
and no statistically significant target BrAC x sex interactions were found. Since the sensitivity of 
each WAB measure to acute alcohol intoxication was the primary focus of the study, follow-up 
pairwise comparisons at each target BrAC were performed (Figure 14). For IC errors, there were 
moderate magnitude (g~0.7) impairments from baseline performance seen at all target BrAC 
levels (Figure16). For global score, significant and moderate magnitude impairments from 
baseline were seen at 0.05% BrAC ascending (g=0.87) and at 0.08% BrAC (g=0.51) (Figure 16). 






Figure 14. Means for each Whack-a-Bottle measure at each target breath alcohol concentration 
(BrAC). a) Whack-a-Bottle percent correct; b) Whack-a-Bottle percent of inhibitory control 
errors; c) Whack-a-Bottle score. Error bars indicate 95% confidence intervals.  
 
 Flanker GNG. No statistically significant main effect of target BrAC for IC errors was 
found (Table 14), indicating that alcohol intoxication did not influence performance. 
Additionally, no significant main effect of sex was found. There was a significant target BrAC x 
sex interaction, although follow up pairwise comparisons found no significant difference 
between males and females across target BrAC. The sensitivity of IC errors to acute alcohol 
intoxication was investigated using follow-up pairwise comparisons at each target BrAC (Figure 
15b). No significant impairments were apparent at all target BrAC levels (ps >.206), indicating 






Figure 15. Means for each traditional inhibitory control measure at each target breath alcohol 
concentration (BrAC). a) stop signal reaction time on the Stop Signal Task; b) number of false 
positives on the Flanker Go/No-go task. Error bars indicate 95% confidence intervals.  
 
Stop Signal Task. There was a statistically significant main effect of target BrAC for 
SSRT (Table 14), indicating that alcohol intoxication influenced performance. A significant 
main effect of sex was also found, however, there was no significant target BrAC x sex 
interaction. Follow up pairwise comparisons were conducted to determine the sensitivity of 
SSRT to acute alcohol intoxication (Figure 15a). There was no significant impairment from 
baseline seen at 0.08% BrAC (g=0.08), while a significant, small impairment was apparent at 






Figure 16. Hedge’s g effect size for each outcome measure of inhibitory control. Error bars 






Interactions and Main Effects of BrAC Target and Sex for Inhibitory Control Measures 
  Target BrAC  Sex  Target BrAC x Sex 
Cognitive task  F df2 p  F df2 p  F df2 p 
WAB:             
 WAB score 11.22 41.54 <.001  4.58 34.01 .040  0.82 41.54 .490 
 Percent errors 11.93 42.65 <.001  0.01 34.80 .930  0.57 42.65 .635 
SST:             
 SSRT 3.33 39.35 .046  4.80 32.35 .036  0.62 39.35 .544 
Flanker GNG:             
 Inhibitory control errors 2.33 43.71 .087  1.22 33.22 .278  2.85 43.71 .048 
Note. Denominator degrees of freedom=df2; numerator degrees of freedom (df1) for Target BrAC and Target BrAC x Sex = 3 for all 
cognitive tasks; numerator degrees of freedom (df1) for Sex = 1 for all cognitive tasks. Whack-a-Bottle=WAB; Stop Signal Task = 






Does the Whack-a-Bottle Task correlate well with traditional measures of inhibitory 
control under alcohol impairment? There were positive, weak magnitude relationships 
between measures of IC errors on the WAB and Flanker GNG at both baseline (r=0.19) and peak 
0.08% target BrAC (r=0.21) (Table 15). Significant, moderate magnitude inverse correlations 
were found between WAB IC errors and SSRT at both baseline (r=-0.36) and peak 0.08% target 
BrAC (r=-0.42). Using the more global measure of WAB score, there was an inverse, trivial non-
significant relationship with IC errors on the Flanker GNG task at baseline (r=-0.05), increasing 
to a weak relationship at peak 0.08% target BrAC (r=-0.13). Non-significant, trivial correlations 
were found between global WAB score and SSRT at both baseline (r=-0.02) and peak 0.08% 
target BrAC (r=0.05). In contrast, IC errors on the Flanker GNG task had a non-significant, 
moderate inverse relationship with SSRT at baseline (r=-0.31), falling to weak at peak 0.08% 
target BrAC (r=-0.17).  
Do measures of inhibitory control correlate with tasks of working memory under 
alcohol impairment? There was a weak inverse relationship between WM performance (percent 
correct on N-back) and WAB IC errors at baseline (r=-0.11), falling to positive and trivial at 
peak 0.08% BrAC (r=0.02). There were insubstantial relationships between WM performance 
SSRT and IC errors on the Flanker GNG at both baseline and 0.08% target BrAC (r<|0.1|; Table 
15). Using the more global measure of WAB Score, there were positive, non-significant weak 





Correlations Between Cognitive Measures at Baseline and at Peak (0.08%) Target Breath Alcohol Concentration 
Cognitive Measures 1. 2. 3. 4. 5. 
1. Whack-a-Bottle score - -0.04 -0.02 -0.05 0.19 
2. Whack-a-Bottle inhibitory control errors 0.16 - -0.36* 0.19 -0.11 
3. Stop Signal Reaction Time 0.05 -0.42* - -.31 0.09 
4. Inhibitory control errors Flanker GNG -0.13 0.21* -0.17 - -0.04 
5. N-back Percent Correct 0.24 0.02 0.03 0.09 - 
Note. Correlations for baseline, 0.00% target breath alcohol concentration on upper diagonal; correlations for peak, 0.08% target 
breath alcohol concentration on the lower diagonal. GNG = Go/No-go 








 The primary aim of the present studies was to assess the performance of the WAB against 
traditional, gold-standard measures of IC. This was achieved by conducting two laboratory-
based, experimental studies. Study one investigated the test-retest reliability of the WAB, while 
also determining its construct validity by examining the correlations between the WAB and 
traditional measures of IC, as well as tasks of WM to determine convergent validity. Results did 
not support the hypothesis that the WAB would demonstrate large magnitude correlations with 
existing measures of IC, with only weak to moderate magnitude correlations found. The 
hypothesis that the WAB and traditional measures of IC would moderately correlate with tasks 
of WM was not supported, with only trivial to weak magnitude correlations found. However, 
results indicated that the WAB is stable over repeated assessment, supporting the hypothesis of 
minimal learning effects between test and retest. Additionally, study two investigated the WAB’s 
sensitivity to acute alcohol impairment. Results supported the hypothesis that the WAB is 
sensitive to acute alcohol intoxication, illustrating that it is a more sensitive measure than 













Summary of Key Findings 
 WAB Flanker GNG SST 
Construct validity 
With Flanker GNG 
   
Weak - Weak 
With SST 
 




   
Trivial - weak Trivial Trivial 
Stability on repeated testing 
Test-retest correlations 
   
Moderate Moderate Strong 
Learning effects 
 
No Yes Likely 
Sensitivity to alcohol 
At 0.05% BrAC 
   
Moderate - large <small small 
At 0.08% BrAC Moderate <small <small 
Note. Pearson’s correlation coefficient (r) representing construct and convergent validity as well 
as test - retest correlations: +/-0 - 0.10 = trivial, +/-0.10 - 0.29 = weak, +/-0.30 - 0.49 = moderate, +/-
0.50 - 1.00 = strong. Hedge’s g effect sizes represent sensitivity to alcohol intoxication: 0.2 = 
small, 0.5 = moderate, 0.8 = large. WAB = Whack-a-Bottle; Flanker GNG = Flanker Go/No-go; 
SST = Stop Signal Task; BrAC = Breath Alcohol Concentration.  
 
 
Does the Whack-a-Bottle Correlate Well with Traditional Measures of Inhibitory Control? 
The WAB produced trivial to moderate magnitude correlations between the Flanker GNG 
and SST in study one (Table 9). Similarly, the Flanker GNG and SST illustrated a weak 
magnitude relationship. Comparable magnitude correlations were also observed in study two at 
both baseline and 0.08% BrAC (Table 15), indicating that the relationships between the IC 
measures remained relatively stable over each study.  




correlate well together, regardless of their commonality. This is consistent with a large body of 
literature that has demonstrated similar poor inter-correlations between measures of IC (Rey-
Mermet, Gade, & Oberauer, 2018). This is supported by Friedman and Miyake (2004) who 
illustrated only weak magnitude correlations between the Stroop and SST (r=0.15, p<.05), and 
Stroop and Antisaccade (r=0.23, p<.05). Tiego, Testa, Bellgrove, Pantelis, and Whittle (2018) 
further supports this, demonstrating a moderate magnitude relationship between IC errors on a 
GNG task and SSRT (r=0.39, p<.001). Consequently, the consistently weak to moderate 
correlations illustrated between measures of IC calls into question the reliability of IC as a 
psychometric construct (Rey-Mermet et al., 2018).  
Bartholow et al. (2018) claims that that the low inter-correlations illustrated between IC 
measures could be a result of IC as a construct demonstrating task-specific variance. This could 
explain why only weak to moderate magnitude relationships were found between the IC 
measures in the present study (Table15). Further, this could account for why the Flanker GNG 
task and WAB only weakly correlated together, even though both tasks are based off comparable 
GNG paradigms. A potential mechanism explaining this task-specific variance is the task 
impurity problem, whereby performance on a task not only reflects the intended EF (in this case 
IC), but also reflects other cognitive processes that are specific to that task (Miyake et al., 2000).  
Since the traditional GNG task utilised in the present research was developed using a 
flanker paradigm, there is the potential that this task also measures attentional processes rather 
than selectively focusing on IC (Aschenbrenner & Balota, 2017). This is supported by the 
Flanker GNG task requiring the capacity to selectively attend to a central target while ignoring 
highly salient, but irrelevant flankers (Brydges et al., 2012). Although the present study was only 




employment of the flanker paradigm has also resulted in the measurement of attentional 
processes, which consequently could be masking the existence of an underlying commonality 
between the WAB and Flanker GNG (Miyake et al., 2000). This could also explain the relatively 
weak relationships found between the Flanker GNG task and other measures of IC; WAB and 
SST (Table 9). Hence, the task impurity problem is likely attenuating the magnitude of the 
correlations between the IC measures.  
Does the Whack-a-Bottle and Other Measures of Inhibitory Control Demonstrate 
Convergent Validity with Tasks of Working Memory? 
Trivial to weak magnitude relationships were found between WM performance (percent 
correct on N-back) and measures of IC (Table 9). Comparable magnitude correlations were also 
observed in study two at both baseline and 0.08% BrAC (Table 15), indicating that the 
relationships between WM and IC performance remained relatively stable over each study. Our 
findings of trivial to weak magnitude correlations between the N-back and measures of IC is 
inconsistent with previous findings. Research consistently illustrates significant moderate to 
strong correlations between WM measures (i.e., N-back; Letter Memory Task; Backwards Digit 
Recall) and traditional tasks of IC (i.e., GNG task; SST; Stroop task; Antisaccade) (Earhart & 
Roberts, 2014; Friedman et al., 2016; Miyake et al., 2000). This is further supported by Tiego et 
al. (2018) where significant moderate inverse relationships were found between the Backwards 
Digit Recall and the GNG task (r=-0.34, p<.001), and also between the SST and Listening Recall 
(r=-0.35, p<.001).  
As previously discussed, debate still exists in the literature regarding whether IC and WM 
are in fact separate cognitive processes or part of an integrated system (Noel et al., 2013). This is 




between the Antisaccade and the Random Number Generation task (r=0.09), and between the 
SST and Reading Span Recall (r=-0.03), suggesting that IC and WM do not have a common 
variance. Our findings support the notion that IC and WM are in fact relatively separate 
processes, as indicated by the trivial to weak magnitude relationships that are illustrated between 
the WM and IC measures (Table 9). However, it should be noted that the task impurity problem, 
as previously discussed, could also be contributing to the lack of commonality between these two 
constructs (Miyake et al., 2000).   
Does the Whack-a-Bottle Have Good Test-Retest Reliability?  
Consistent with our hypothesis, the WAB IC measures produced no learning effects over 
repeated assessment as indicated by Bayesian and paired samples t-tests (Table 11). Since the 
WAB utilises a random nature (i.e., bottles appear randomly), it is likely that strategy generation 
is limited, hence learning effects are unlikely to occur. The WAB also demonstrated moderate 
magnitude test-retest correlations, indicating that performance was relatively stable across retest; 
the magnitude of these correlations were equivalent with the Flanker GNG task, but were 
reduced compared to the SST (Table 10).  
A potential reason for these findings is that the WAB demonstrated ceiling effects 
(Table16; Figure 7b), with a large proportion of participants having perfect performance on the 
task, hence making no IC errors. It is likely that these ceiling effects are attenuating the test-
retest correlations between the WAB, possibly explaining the reduced magnitude test-retest 
correlation compared to the SST. There also is the potential that these ceiling effects have 
masked the presentation of practice effects over repeated assessment. This is because the ceiling 
effects create an upper limit on the ability of the WAB to change from test to retest, as 




The Flanker GNG and SST also demonstrated moderate and strong magnitude test-retest 
correlations, respectively. These findings are consistent with a large body of research that has 
demonstrated that performance on a range of IC tasks (i.e., SST; GNG; Stroop; Antisaccade; 
Flanker) is associated with performance across a test-retest period (Friedman & Miyake, 2004; 
Friedman et al., 2016; Rey-Mermet et al., 2018). Specifically, Bender, Filmer, Garner, Naughtin, 
and Dux (2016) has illustrated strong magnitude test-retest correlations for SSRT (r=0.60), GNG 
commission errors (r=0.62), Stroop congruency effect (r=0.57), and Flanker RT (r=0.75).  
Despite performance remaining consistent across test-retest, it is consistently 
demonstrated that performance on current IC measures significantly improves over repeated 
assessment (Beglinger et al., 2005; Langenecker, Zubieta, Young, Akil, & Nielson, 2007; 
Schapkin, Falkenstein, Marks, & Griefahn, 2007). Weafer et al. (2013) further supports this, 
demonstrating that paired samples t-tests revealed significant differences between test and an 
eight day retest on the SST (d=0.60), indicating that performance on the task improved on 
repeated assessment. This is partly consistent with our findings, with the Flanker GNG 
demonstrating learning effects over repeated assessment (Table 11), suggesting that when 
undertaking the task, participants’ adopted task strategies, hence improving their performance on 
subsequent testing due to learning (Figure 8b). However, performance on the SST was shown to 
significantly worsen over the test-retest period (Table 11). Although inconsistent with past 
research (Soreni, Crosbie, Ickowicz, & Schachar, 2009), this unexpected finding illustrates that 
performance on the SST is not stable over repeated assessment (Figure 8a), indicating that the 
task is not appropriate for subsequent use and that it may be falsely sensitive to IC impairment 




Did Participants Enjoy Whack-a-Bottle More Than Traditional Measures of Inhibitory 
Control? 
 Participants reported a better user experience with the WAB compared to a comparative, 
traditional measure of IC; SST (Figure 9). It is likely that the ‘serious games’ approach used in 
the development of the WAB has enhanced engagement of the cognitive test through a more 
dynamic and interactive display. Sounds, bright colours, feedback (i.e., game scores) and 
motivational properties (i.e., receiving points for correct responses and losing points for incorrect 
responses) have improved the appeal of the cognitive test to participants, hence improving the 
acceptability of task.  
Is the Whack-a-Bottle Sensitive to Impairment From Acute Alcohol Intoxication? 
 The WAB is a more sensitive measure to alcohol impairment across target BrAC than 
other traditional measures of IC; SST and Flanker GNG (Figure 16). A potential reason that 
could explain the greater sensitivity of the WAB is that the WAB utilised a greater number of 
trials in comparison to the traditional measures of IC. Subsequently, the WAB produced a greater 
number of opportunities to make IC errors, with 16 no-go trials presented compared to 12 stop 
signals in the SST and 8 no-go trials in the Flanker GNG; it should be noted that these tasks 
contain a small amount of trials as they have been designed to be extremely brief (Cash, 
Peacock, Barrington, Sinnett, & Bruno, 2015). Hence, this could explain the WAB’s greater 
sensitivity to IC impairment across target BrAC because participants’ had a greater likelihood of 
making IC errors compared to the other IC tasks. Despite this, even under alcohol impairment, 
people still tended to make no IC errors on the WAB (Table 17), suggesting that the WAB’s 
difficulty needs to be increased in order to be a more accurate measure of IC.  




response as more go trials are presented compared to the SST and Flanker GNG tasks. The WAB 
produces a 84% probability that a go stimuli will be presented, while the SST and Flanker GNG 
have a 75% and 72% probability, respectively. Subsequently, the WAB may elicit a stronger 
prepotent response compared to the traditional measures of IC. Bartholow et al. (2018) argues 
that strong prepotency is pertinent to elicit sensitivity to IC impairment. Hence, the stronger 
prepotent response produced in the WAB could be a possible factor that is contributing to the 
task’s greater sensitivity under alcohol impairment.  
 The differing sensitivity between the IC tasks could also be influenced by the distinctive 
aspects of inhibition that are measured (Bartholow et al., 2018). As shown in Table 4, the GNG 
task has consistently been shown to have increased sensitivity to the acute effects of alcohol 
compared to the SST. This is likely due to the SST requiring higher EFs to perform the task due 
to it measuring controlled inhibition, where a response needs to be inhibited after its initiation, 
rather than automatic inhibition in GNG tasks, where a prepared response is withheld that has not 
been initiated, which is less cognitively demanding (Littman & Takacs, 2017). This potentially 
explains why the SST did not detect significant impairments in SSRT at peak 0.08% BrAC and 
was associated with a trivial magnitude effect size (Figure 15a). However, a small magnitude 
significant impairment was detected at 0.05% descending target BrAC. These findings are partly 
consistent with the majority of research (Table 4; Cash et al., 2015) that has found that the SST is 
not sensitive to alcohol impairment across the alcohol curve. Although a significant impairment 
was observed at 0.05% descending target BrAC, it is possible that this reflects fatigue effects 
under alcohol intoxication (Bartholow et al., 2018).  
Although the Flanker GNG task is also based off a GNG paradigm, it is claimed to 




Balota, 2017). Consequently, the Flanker GNG task is argued to be a less sensitive measure of IC 
(Bender et al., 2016). This could explain for why no IC deficit was detected across target BrAC 
in the Flanker GNG (Figure 15b) compared to the WAB. The absence of a IC deficit measured 
using the Flanker GNG could also be a result of practice effects. As shown in Table 11, the 
Flanker GNG exhibited strong evidence of learning effects over repeated assessment. 
Subsequently, the repeated completion of the task over each target BrAC could have resulted in 
task learning, leading to alcohol induced impairments in IC to be masked. This is supported by 
Figure 15b illustrating that less IC errors were made at 0.05% descending target BrAC compared 
to baseline. Hence, it is possible that practice effects have weakened the sensitivity of the 
Flanker GNG task.  
Limitations and Future Directions 
 While methodologically sound, the reliability of the results obtained for the WAB are 
limited due to a large proportion of participants making no IC errors on the task, hence 
producing ceiling effects (Table 17). In comparison to the Flanker GNG, the WAB produced a 
substantially larger proportion of ceiling effects, with over 50% of participants making no IC 
errors on both test and retest. The discrepancy between the WAB and Flanker GNG indicates 











Percent of No Inhibitory Control Errors on the Whack-a-Bottle and Flanker Go/No-Go Tasks 
 Number of no inhibitory control errors 
Inhibitory control task Test Retest Alcohol impairment 
Whack-a-Bottle 53.7% 55.9% 17.1% 
Flanker Go/no-go 13.2% 25.0% 12.6% 
Note. Alcohol impairment includes 0.05% ascending, 0.08% peak, and 0.05% descending breath 
alcohol concentration.  
 
These ceiling effects have the potential to attenuate the correlations between the WAB 
and other measures of IC, as well as the test-retest correlations on the WAB. This is a result of 
ceiling effects artificially depressing the magnitude of correlations by restricting the distribution 
range of the dataset (Goodwin & Leech, 2006). Consequently, this could explain for the trivial to 
moderate magnitude correlations illustrated between the WAB and traditional measures of IC, as 
well as accounting for the weaker magnitude test-retest correlations exhibited by the WAB. 
Hence, it is likely that the magnitude of the correlations found are not representative of their true 
value if comparable ceiling effects were found between the Flanker GNG and WAB.  
Although the ceiling effects on the WAB are potentially reducing the reliability of the 
results obtained from this research, it is now apparent that further development of the task is 
required to reduce these ceiling effects. This is supported by Table 17, which illustrates that the 
drop in the percent of perfect performance on the WAB under alcohol intoxication strongly 
argues for making the task more difficult. This can be achieved by increasing the number or 
speed of trials and/or decreasing stimulus presentation time, which can be easily managed in task 
configuration settings.  
Future research should aim to replicate the present findings with a more difficult version 




traditional IC measures and to obtain normative data for standardised assessment. Additionally, 
future research should investigate the use of the WAB for ICT in substance-dependent 
individuals, whereby IC is strengthened through repeated inhibition of a prepotent response to 
salient stimuli (Luijten et al., 2014). As previously discussed, ICT has been shown to reduce 
alcohol consumption when no-go targets are repeatedly paired with alcohol-related stimuli 
(Jones et al., 2016). Hence, the WAB has been specifically developed to foster ICT in substance-
dependent individuals through the use of alcohol-related no-go targets. Since the WAB is 
compatible with most Android devices, the practicality of its use in ICT is further enhanced 
through the portability of the task, as treatment retention is poor in substance-dependent 
individuals (Wilcox et al., 2014).  
Conclusion and Implications 
 The present study examined the psychometric quality of the WAB against traditional gold 
standard measures; SST and Flanker GNG, to determine whether it was a valid and sensitive 
measure of IC. Results revealed that the WAB demonstrates good face validity and equivalent 
reliability with traditional measures of IC. The WAB also demonstrated minimal learning effects 
over repeated assessment, while comparative IC measures revealed that performance was not 
stable across test-retest. However, it is likely that the substantial proportion of participants 
displaying no IC errors on the WAB could be attenuating the magnitude of the correlations 
between the tasks and obscuring the potential for learning effects. Hence, reliability could be 
improved by further development of the task to reduce ceiling effects. Finally, it was 
demonstrated that the WAB was a more sensitive measure to acute alcohol impairment across 
target BrAC than other traditional measures of IC, with large magnitude deficits in IC 




These findings illustrate that the WAB has the potential to be a sensitive and robust 
measure of IC that could be used for research purposes and in treatment contexts for ICT in 
substance dependent populations. The WAB has been specifically developed using a ‘serious 
games’ approach to be free, portable and brief, with automated scoring and interpretation. Its 
simplicity allows for no specialist knowledge to be required for administration, making it freely 
accessible to clinicians and the research community. Hence, the practicality of the WAB 
accommodates the needs of researchers and clinicians, while also enhancing the engagement of 
its consumers through motivational properties. However, before use in these contexts, further 
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Information sheet: Study One 
Validation of brief mobile/tablet based assessments of 
processing speed, inhibitory control and impulsivity  
  
Invitation  
This is an independent study conducted by Associate Professor Raimondo Bruno, in the School 
of Medicine (Psychology) at the University of Tasmania. Other researchers involved in the study 
include Dr Matthew Gretton, who programmed one of the tasks, and Tanya Wilson, Edin Van 
Der Kley and Megan Young as part of their research for the degree of Honours in psychology.  
 
1. What is the purpose of this study?  
We have developed three new tests that can be used on mobile smartphones or tablets. They 
will look at processing speed, inhibitory control, and impulsivity. We want to make these freely 
available for other researchers and for clinical purposes. Before we can put these new tests out 
to be used, we need to make sure that the new tests on mobile phones/tablets work in the same 
way as pencil and paper-based and other versions of the tasks. We also need to make sure 
that they give a reliable measure of people’s processing speed, inhibitory control and impulsivity 
– and by that we mean that it should give you similar results if you repeat the test. Once we 
have tested these, then we will be able to confidently use the new test in research studies and 
make them available for others to use.  
 
Processing speed is basically a measure of how quickly your brain can deal with information 
and make decisions. For example, working out if something on a computer screen is an X or a 
Y; or seeing if there is a match among a group of images. Processing speed is an important part 
of cognition (thinking) because it is a skill that is necessary for performing well in a number of 
different areas. For example, how well you can work with information in working memory (such 
as doing maths problems in your head) depends on how quickly you can process information. 
This new test is based on a very well used task that is usually done with pencil and paper. We 
have made a new and harder version that works on mobile phones so that we can measure 
processing speed in real world contexts. In the future, we’re hoping to use this task to do things 




machinery; to measure processing speed over the course of an evening out while people are 
drinking alcohol; or over the course of attending music festivals.   
Inhibitory control is how good you are at stopping responses once you’ve started. For 
example, like when you have started to move into a different lane while driving but suddenly 
notice a car in your blind spot, so you shift back into your original lane. The ability to do this skill 
is really important for a number of areas, but in particular things like being able to withstand 
cravings and staying abstinent when you’re trying to stop smoking or drinking. The existing 
measures for this are good but both expensive and pretty boring for people to complete. We 
have developed a new measure that we hope is more interesting, based on the traditional 
‘whack-a-mole’ game.  
  
Impulsivity is about whether your decisions are focused on immediate reward or what is better 
for you in the long term. Like, for example, when you are hungry and need to choose between 
satisfying but unhealthy foods (like hot chips) and less satisfying but more health foods (like 
fruit). We have made a short version of a questionnaire that asks about preferences for 
immediate vs long term rewards.  
  
2. Why have I been invited to participate?  
We’re inviting any adults between 20 and 64 who are healthy and not taking any 
medications that are willing to help us validate these tasks.   
We’re not just asking people who are university students to take part, but if you are involved 
with the University of Tasmania, you should know that if you don’t want to take part in this study, 
that is OK, and it is not going to have any impact on the way you are treated by the University. If 
you start taking part in this study, and decide that you don’t want to continue, that’s not going to 
have any impact on how the University will treat you either.  
 
3. What will I be asked to do?  
There’s two parts to this study. Each part will take between 30 and 45 minutes.   
After making sure that you are eligible to take part, you will be given some tests of cognition 
(thinking). These might ask you to pronounce some unusual words out loud (like ‘yacht’), to pick 
the direction of an arrow on screen as quickly as possible, to work out whether there are 
matches in a group of images. Each of these are pretty short (2-4 minutes) and are designed to 
be tricky.  




Processing speed:  What you will need to do is to work out, as quickly as possible, if any of a 
group six images on screen are an exact match to either of two target images. There will be a 
lot of these trials, and about half of them will be matches and half of them won’t match.  
  
Inhibitory control: This is just like a game of ‘whack-a-mole’. Here, different sorts of bottles will 
pop up on a screen, one at a time. As quickly as possible you have to smash any bottles of 
healthy drinks (like water or oange juice). Every now and then, a bottle of alcohol (beer or wine) 
will pop up, and you have to avoid hitting those ones. You will have around 100 trials to get as 
many points (for hitting the right targets) as possible.  
  
Impulsivity: Here you just need to answer a bunch of ‘would you rather’-type questions. For 
example, you might be asked “Would you prefer $54 today or $55 in 117 days?”. All you have 
to do is pick whether you would, hypothetically, prefer to have the money today or to wait for the 
larger option. There are no ‘right’ or ‘wrong’ answers, we’re just interested in your opinion.  
You can take regular breaks (we’ll remind you about this option).   
About a week later, we’d like you to invite you to come back and do the same tasks again. This 
might seem a little pointless, but knowing how much people’s performance changes after they 
have done the task is critically important if we are going to use the test in repeated studies.   
It is important to know that it’s up to you whether you want to do any of these bits of the study, 
and if you are only ok with some parts and not others, that’s ok, you can still take part in the bits 
of the study that you are comfortable with.  
 
4. Are there any possible benefits from participation in this study?  
The main benefit from taking part in this study is making a contribution to science by making 
sure that the tests we use are valid.   
We appreciate your time and inconvenience in contributing to research, and we are able 
to provide reimbursement of $10 for each of the sessions ($20 in total, paid once you’ve 
completed both parts). If you decide to do only one part, we will of course provide the amount of 
payment for the part you complete.   
 
5. Are there any possible risks from participation in this study?  
These tests are all designed to be challenging, but it is unlikely that you would find them 




mistake but the tests are all designed to be challenging enough so that everybody is going to 
make mistakes somewhere.   
We are going to keep your personal details confidential. The consent forms with identifying 
information (such as your contact details) are kept separately from all other information from this 
study (such as the questions about your substance use). They are stored securely at the 
University. All information from the study is stored only with a study ID (e.g. CTX777). As soon 
as you complete the study, any link between your identifying information and study ID is 
securely destroyed, making it very difficult for an individual person to be identified by their data.  
 
6. What if I change my mind during or after the study?  
As noted above, it is completely fine for you to decide not to answer any questions that you’re 
not comfortable with. That won’t affect your relationship with the University. The same applies if 
you start the study and then decide that it is not for you. You don’t need to explain why. If you 
decide to withdraw, you will still receive reimbursement for your time involved in the study, on a 
pro-rata basis.  
If you decide that you don’t want to be part of the study, and you let us know before the end of 
your participation in the study, we’ll be able to work out which data is yours and we can delete 
all records and securely destroy any consent forms. If you let us know after you have finished all 
the parts of the study, we won’t be able to remove your data because we would have destroyed 
the links between your identifying information and the study ID.   
 
7. What will happen to the information when this study is over?  
Identifying information will be destroyed as soon as any individual participant completes their 
part of the study. All the information about performance on the different tasks are stored only 
using study ID. This will be stored in an electronic database, on secured University of Tasmania 
servers, and password protected. Hard copies (of your consent form with no link to a study ID) 
are stored in locked filing cabinets in University of Tasmania storage archives. Both electronic 
and hard copy data will be destroyed five years after the first publication from this study.   
A reminder: any information obtained for the purpose of this study that can identify you will be 
destroyed as soon as you have completed your part in the study or withdrawn your consent. All 
information, regardless of whether it is identifying or not, will be treated as confidential and 
always securely stored.  
The data from the tests doesn’t provide any useful diagnostic information – it is mainly just 




get tired, or consume alcohol, or are prescribed medications and the like. Because of this, we 
are not planning on providing any feedback about your performance to you.   
 
8. How will the results of the study be published?  
Study findings will be presented in formal publications and in conference presentations. Only 
group level analyses will be reported, so there is no way that a particular individual could be 
identified in any publication. The results will be available on the university of Tasmania 
publications repository, WARP (https://rmdb.research.utas.edu.au/public/rmdb/q/warp_home) or 
specifically 
here: https://rmdb.research.utas.edu.au/public/rmdb/q/indiv_detail_warp_trans/3812#research-
tab-5. You can also contact Raimondo Bruno directly here: Raimondo.Bruno@utas.edu.au  
 
9. What if I have questions about this study?  
If you have questions about the study, you can contact Raimondo Bruno at 03 6226 2240 
or Raimondo.Bruno@utas.edu.au. This study has been approved by the Tasmanian Social 
Sciences Human Research Ethics Committee. If you have concerns or complaints about the 
conduct of this study, please contact the Executive Officer of the HREC (Tasmania) Network 
on +61 3 6226 6254 or email human.ethics@utas.edu.au. The Executive Officer is the person 
nominated to receive complaints from research participants. Please quote ethics reference 
number [H0018073].  
 
Thank you for your interest in the study, and your time in reading this information sheet. 
This is for you to keep. If you want to take part in this study, there is a consent form for 












Consent Form: Study One 
 Validation of brief mobile/tablet based assessments of 
processing speed, inhibitory control, and impulsivity  
Consent form for participants  
  
1. I agree to take part in the research study named above.  
2. I have read and understood the Information Sheet for this study.  
3. The nature and possible effects of the study have been explained to me.  
4. I understand that the study involves completion of a number of brief tests, on computers, 
and pencil and paper, of my thinking.   
5. I also understand that I will be asked to come to a second session to repeat these 
tasks, in order to measure how test performance holds up over time.  
6. I understand that participation involves no foreseeable risks.  
7. I understand that all my data will be labelled only with a study ID, not my name or any 
other identifying information, and that any link between my name and Study ID will be 
destroyed as soon as I have completed my role in the study, whether that be by completion 
of both sessions or if I decide to discontinue for any other reason.  
8. I understand that all research data will be securely stored by study ID only on the 
University of Tasmania premises for five years from the publication of the study results, and 
will then be securely destroyed.   
9. Any questions that I have asked have been answered to my satisfaction.  
10. I understand that the researcher(s) will maintain confidentiality and that any information I 
supply to the researcher(s) will be used only for the purposes of the research.   
11. I understand that the results of the study will be published so that I cannot be identified 
as a participant.   
12. I understand that my participation is voluntary and that I may withdraw at any time 
without any effect.   
I understand that I will not be able to withdraw my data after completing all parts of the 
study, as any links with identifying information will have been destroyed. Before this 







Participant’s name:  _______________________________________________________   
  
Participant’s signature: ____________________________________________________  
  
Date:  ________________________  
  
  
Statement by Investigator    
  I have explained the project and the implications of participation in it to this 
volunteer and I believe that the consent is informed and that he/she understands 
the implications of participation.  
If the Investigator has not had an opportunity to talk to participants prior to them participating, 
the following must be ticked.  
  The participant has received the Information Sheet where my details have been 
provided so participants have had the opportunity to contact me prior to consenting 
to participate in this project.  
  
Investigator’s name:  _______________________________________________________   
  
Investigator’s signature: ____________________________________________________  
  



































































Ethics approval: Study Two 
Sent via email 
From: human.ethics@utas.edu.au 
Sent: Monday, 6th May 2019 10:22AM 
To: Raimondo Bruno 
Cc: Amy Peacock; Olivia Maynard; Jane Akhurst; Thomas Norman; Erin Van Der Kley; Tanya 
Wilson; Megan Young 
Subject: Notification of Amendment Approval: H0016125 Longitudinal Study on Alcohol, Harm 
and Cognitive Performance in the Festival Environment 
 
Dear AssocProf Bruno, 
 
Ethics Ref: H0016125 
Title: Longitudinal Study on Alcohol, Harm and Cognitive Performance in the Festival 
Environment 
 
This email is to confirm that the following amendment was approved by the Executive Officer 
on behalf of the Tasmania Health and Medical Human Research Ethics Committee on 6/5/2019: 
 
Amendment Additional Staff: Erin Van Der Kley, Megan Young, Tanya Wilson 
Information Sheet PITP Information Sheet - Apr2019 
 
All committees operating under the Human Research Ethics Committee (Tasmania) Network are 
registered and required to comply with the National Statement on Ethical Conduct in Human 
Research (NHMRC 2007). 
 
This email constitutes official approval. If your circumstances require a formal letter of 
amendment approval, please let us know. 
 






Office of Research Services 
University of Tasmania 
Private Bag 01 














































































        Appendix H 
          Information Sheet: Study Two 
 
 







Alcohol Intoxication, Transdermal Alcohol Assessments and Cognitive Performance  
 
 
Version 4, April 2019 
 
Introduction 
You are invited to participate in a study examining the relationship between transdermal alcohol 
assessments, cognitive performance and alcohol intoxication. This research is being conducted 
by Thomas Norman, as partial fulfilment of a Doctor of Psychology degree. Thomas is being 
supervised by Associate Professor Raimondo Bruno and Dr Amy Peacock from the School of 
Medicine (Psychology), University of Tasmania. In addition, this research will be part of the research 
conducted by Erin van der Kley, Megan Young and Tanya Wilson for their Honours in Psychology. The 
key researchers can be contacted as following: Thomas Norman 
(Thomas.Norman@utas.edu.au) or Raimondo Bruno (Raimondo.Bruno@utas.edu.au).  
 
What is the purpose of the study? 
The purpose of this study is to investigate the degree to which transdermal alcohol 
concentration relates to alcohol intoxication and cognitive performance (e.g., reaction time, 
accuracy, decision-making,) outcomes.  
 
Who can participate? 
We are currently seeking participants who are: 
• Male or female 
• Aged 18 years or over 
• Completed Year 12 
• Normal or corrected-to-normal vision 




• Healthy (no history of significant neurological disorder or current psychiatric disorder, 
significant intellectual disorder, alcohol/drug dependence, regular tobacco use, or 
chronic health problems) 
• Regular alcohol consumers (minimum consumption of 2 standard alcoholic drinks on 
one occasion in the preceding month) 
• Not currently using illicit drugs (i.e., use in the preceding six months) 
• Able to attend the Hobart campus of the University of Tasmania for one three hour session 
conducted between 9am and 7pm.  
 
What does participation in the study involve? 
This research will be conducted in the Perception Laboratory at the School of Psychology, 
University of Tasmania (Hobart). Interested individuals will complete a brief screening 
questionnaire that collects data about demographics (e.g., age, sex), medical history, 
pregnancy/breastfeeding status (females only), psychological wellbeing, reading ability, use of 
alcohol and other drugs. Eligible participants will be asked to attend one three hour session at 
the psychopharmacology laboratory.  
 
If participants are deemed eligible, they will be invited to participate in a laboratory session. 
During this session, participants will be dosed with alcohol (up to .05 breath alcohol 
concentration) and asked to complete a series of cognitive tasks on a tablet. A breathalyser 
will be used to monitor participants’ breath alcohol concentration throughout the duration of 
the study. They will be fitted with a continuous alcohol monitoring bracelet around their 
ankle, which will be worn during the course of the session and taken off before they leave. 
This bracelet can be taken off at any time if the participant wishes to do so. Session length is 
dependent on the time taken for the participant to record two consecutive breath alcohol 
readings of .03% or less (.00% for Provisional licence holders intending to drive). Depending 
on the individual’s rate of alcohol absorption and elimination this time may vary and 
therefore some sessions may take longer than three hours to complete. 
 
What are the restrictions regarding participating? 
Participants will be asked to abstain from alcohol and over-the-counter medication for 24 hours 
prior to the laboratory session. Participants will be asked to abstain from illicit drugs and 
tobacco for the duration of participation.  
  
At the end of the laboratory session, participants will remain at leisure (with food and 
entertainment provided) until they attain two consecutive breathalyser recordings of 0.03% or 
less measured 15 minutes apart. 
 
Participants holding their provisional driver licence, who are intending to drive will be required 
to remain in the laboratory until two consecutive BrAC measurements are recorded at .00%.  
Participants holding their provisional licence who are not intending to drive, will be able to leave 
the laboratory at .03% BrAC if they sign a declaration in which they agree to be escorted by a 
nominated guardian to their place of residence and accompanied for a two hour period following 
session completion. The nominated guardian must be an adult aged 18 years or older who: (i) 
holds their provisional or full driver licence (ii) directly collects the participant from the research 




participant directly to their place of residence and accompany the participant for the two hour 
period following session completion. The researcher reserves the right to retain participants in 
the laboratory until .03% BrAC for those holding their full driver licence and .00% BrAC for 
those holding their provisional licence when it is deemed unsafe for the participant to leave at 
.03% BrAC. 
 
What are the benefits of participating? 
Your participation will help us enhance our knowledge of the effects of alcohol on 
transdermal readings and on cognitive performance outcomes. This knowledge can be 
used to help educate people and the scientific community regarding the potential outcomes 
and utility of these measures in alcohol-related research.  
 
What are the risks associated with participating? 
There are no anticipated risks of this research. However, if in the unlikely event you experience 
negative side-effects, please inform the experimenter and the necessary assistance will be sought 
and provided. We ask that participants refrain from consuming alcohol or operating heavy 
machinery for four hours post-laboratory session. 
 
Is there any monetary reimbursement for participation? 
Participants will be reimbursed $50 for participation in the session.  
 
How do I volunteer to participate? What if I want to withdraw from participating? 
Participation in this study is voluntary. By signing the attached consent form, you are 
indicating that you are aware of the nature of the study and wish to participate. While we 
would be pleased to have you participate, we respect your right to decline. There will be no 
consequences to you if you decide not to participate. If you decide to discontinue participation 
at any time, you may do so without providing an explanation. However you will be required to 
remain in the laboratory until your breath alcohol concentration measurement equals 0.03% or 
less on two separate occasions measured 15 minutes apart. 
 
What will happen to the information I provide? 
All information collected will be kept confidential. Each participant will be assigned a code and 
individual participant data will be identifiable only by that code. All of the data will be stored on 
password protected secure computers or in a locked cabinet in the School of Psychology for a 
minimum of five years after the publication of any academic journal articles, at which point all 
questionnaires will be destroyed using a paper shredder and electronic data will be deleted. The 
screening questionnaire will be securely destroyed immediately on completion of the study and 
that any information provided by the participant on the questionnaire will be identifiable only by 
participant number, kept confidential, and viewed only by the experimenter. 
 
Who do I contact if I have any queries? 
If you would like to discuss any aspect of this study please contact Thomas Norman 
(Thomas.Norman@utas.edu.au). Alternatively, you can contact Dr Raimondo Bruno on (03) 
6226 2240 or email Raimondo.Bruno@utas.edu.au. 
 




A summary of the results will be available on the Research webpage of the School of 
Psychology, University of Tasmania (http://fcms.its.utas.edu.au/scieng/psychol/). Results of the 
study can also be provided by Thomas Norman (Thomas.Norman@utas.edu.au).  
 
Who do I contact if I have a complaint about the study? 
This study has been approved by the Tasmanian Social Science Human Research Ethics 
Committee. If you have concerns or complaints about the conduct of this study should contact 
the Executive Officer of the HREC (Tasmania) Network on (03) 6226 7479 or email 
human.ethics@utas.edu.au. The Executive Officer is the person nominated to receive 
complaints from research participants. You will need to quote H0016125. 
 
Who do I contact if I wish to speak to someone about my alcohol or drug use, or mental 
health? 
As aforementioned, a number of simple screening questionnaires will be administered 
assessing psychological functioning and alcohol and other drug use. Whilst it is not anticipated 
that these questionnaires will cause distress, please do not hesitate to let the researcher know if 
you do not wish to fill them in. If you are concerned about your drinking or mental health, 
please contact the Tasmanian Alcohol Drug Information Service 1800 811 994 or Lifeline 13 
11 14 (both services available 24 hours a day). 
 
Thank you for taking the time to consider this study. 
If you wish to take part in it, please sign the attached consent form. 


















Consent Form: Study Two 
  
  
                                                        School of Psychology 
                                                       University of Tasmania 
  
                                                              Consent Form 
  
Alcohol Intoxication, Transdermal Alcohol Assessments and Cognitive Performance   
  
  
1.I have read and understood the 'Information Sheet' for this project.  
2.The nature and possible effects of the study have been explained to me.  
3.I understand that the study involves attending the Cognitive Neuroscience Laboratory for 
one four to five hour session. This can be completed on a mutually convenient day of your 
choosing.  
4.I understand that my height, weight, reading ability, psychological wellbeing, demographic 
information, drug and alcohol use history and pregnancy/breastfeeding status (females 
only) will be assessed to ensure my eligibility for participation. I understand that 
in the session I will complete measures of cognitive performance and alcohol use, as well as 
having my height and weight measured.   
5.I understand that I will be asked to 
sign a declaration and complete a breath alcohol concentration measurement (via a 
breathalyser) to confirm my abstinence at the start of the laboratory session.  
6.I understand that in the laboratory session I will receive a beverage containing alcohol. I 
understand that I will be given enough alcohol to receive a breath alcohol reading of .05. I 
understand that after beverage consumption, I will be asked to 
complete a number of laboratory cognitive-behavioural performance tasks during which 
my behavioural responses will be recorded. I understand that my breath alcohol concentration 
will be recorded throughout the laboratory session.  
7.I understand that I will be asked to remain in the laboratory until my blood alcohol 
concentration equals 0.03% or less on two occasions measured 15 minutes apart. I 
acknowledge that I have been advised to refrain from drinking alcohol or operating a vehicle 
or other heavy machinery for four hours after the end of the experimental session.  
8.I understand that if I hold a provisional driver licence and I intend to drive I will be 
required to remain in the laboratory until my breath alcohol concentration is .00% on two 
consecutive occasions. I understand that if I hold a provisional driver licence and do not 
intend to drive I will be able to leave the laboratory at .030% BrAC after signing a 
declaration in which I agree to be escorted by my nominated legal adult to my place of 




understand that the nominated legal guardian must be an adult aged 21 years or older who: (i) 
holds their provisional or full driver licence (ii) directly collects me from the research premises 
and meets the researcher in-person, and (iii) signs a declaration agreeing to escort me 
directly to my place of residence and accompany me for the two hour period following session 
completion. Furthermore, I understand that the researcher reserves the right to retain 
participants in the laboratory until .03% BrAC for those holding their full driver licence and  
.00% BrAC for those holding their provisional licence when it is deemed unsafe for the 
participant to leave at .03% BrAC.  I acknowledge that I have been advised to refrain from 
drinking alcohol or operating a vehicle or other heavy machinery for four hours after the end 
of experimental sessions.  
9. I understand that I will be fitted with a continuous alcohol monitoring bracelet during 
the sessions, but that I may take this off at any time and for any reason.   
10.I understand that I will be provided reimbursement to the sum of $50 for participation. If I 
withdraw from the study prior to concluding all sessions I will not be eligible for 
monetary reimbursement, unless the withdrawal is due to an unexpected adverse event.   
11.I understand that, while there are no anticipated risks associated with this study, I 
should inform the experimenter immediately if any unexpected negative side-effects are 
experienced. I understand the experimenter will immediately cease the session and seek the 
necessary assistance. I understand that I can contact the researchers, Lifeline or the 
Tasmanian Drug Information Service should I experience any adverse (phone numbers have 
been provided on the information sheet).  
12.I understand that the researchers will maintain my confidentiality and that any 
information I supply to the researcher(s) will be used only for the purposes of the research. 
My data will only be identifiable by an individual numerical participant code.  
13.I understand that the screening questionnaire will be securely destroyed immediately on 
completion of the study and that any information I provide will be 
identifiable only by my participant number, kept confidential, and viewed only by the 
experimenter.  
14.I understand that all research data will be securely stored on the University of 
Tasmania premises for at least five years, and will then be securely destroyed when no longer 
required.  
15.I agree that research data gathered from me for the study may be published provided that I 
cannot be identified as a participant.  
16.I agree to participate in this investigation and understand that I may withdraw at any 
time without any effect, and if I so wish, may request that any data I have supplied to date be 
withdrawn from the research.  




Name of Participant   ___________________  
Signature of Participant ____________________  
Date ___________________  
  
  





I have explained the project & the implications of participation in it to this 
volunteer and I believe that the consent is informed and that he/she understands 
the implications of participation.   
  
If the Investigator has not had an opportunity to talk to participants prior to them 
participating, the following must be ticked.   
  
  
The participant has received the Information Sheet where my details have been 
provided so participants have the opportunity to contact me prior to consenting to 
participate in this project.  
  
Name of Investigator ___________________  
Signature of Investigator ____________________  
Date ___________________  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
